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ABSTRACT 
Mediator is a multiprotein complex required for the regulation of RNA 
Polymerase II (Pol II) transcription. Mediator transmits regulatory signals 
from activators and repressors to the Pol II machinery at the promoter, but the 
complex has also many other functions related to control of gene 
transcription. This thesis aims to expand our knowledge of Mediator’s 
involvement in regulation of the specialized chromatin structures found at 
telomeres and centromeres as well as its role in regulation of non-coding 
RNA transcription. 
A fine-tuned balance between the histone deacetylase Sir2 and the histone 
acetyltransferase Sas2 determines the location of the boundary between 
active and inactive chromatin at budding yeast telomeres. In our work, we 
demonstrate that Mediator interacts with heterochromatin at telomeres and 
directs the position of this boundary. Mutations in Mediator subunits cause a 
depletion of the complex from heterochromatin, which changes the balance 
between Sir2 and Sas2, and ultimately results in desilencing of subtelomeric 
regions. Telomeres are important regulators of replicative life span, which is 
reduced as a consequence of mutations in the Mediator complex. 
The Schizosaccharomcyes pombe centromeres are also characterized by silent 
heterochromatin, which is assembled and maintained through a complex 
multifactorial system. In our work, we find that Mediator is involved in 
formation of these heterochromatin structures. Loss of the Mediator subunit 
Med20 causes disruption of heterochromatin and leads to increased 
transcriptional activity at the centromere. The med20∆ mutant also causes 
reduced levels of CENP-ACnp1, a centromere specific form of histone H3 
found at centromeres, and chromosome instability during cell division. 
Previous data have demonstrated that pericentromeric transcription may 
contribute to heterochromatin formation at pericentromeres via two parallel 
mechanisms, one depending on the exosome RNA degradation complex and 
one dependent on the RNAi machinery. In our work, we find that inactivation 
of the exosome can reverse the increased levels of pericentromeric 
transcription observed in med20∆ cells, but that it fails to alleviate the 
chromosome segregation defects. Furthermore, loss of Med20 leads to a 
changed pattern of siRNA products, which is not further affected in the 
med20∆/rrp6∆ strain. Our results therefore suggest that Mediator and the 
exosome act in partially independent pathways to influence centromere 
function.  
We also demonstrate that Mediator influences RNA polymerase III (Pol III) 
transcription. Deletion of med20+ results in increased transcription of 
ribosomal protein genes, but also affects Pol III transcription causing an 
accumulation of aberrant tRNA transcripts with evidence of incorrect 
transcription termination. The aberrant transcripts are polyadenylated and 
targeted for degradation by the exosome. The effects of Mediator on Pol III 
transcription are distinct from those involving Maf1, the classical repressor of 
Pol III activity. Based on our findings we suggest that fission yeast Mediator 
takes part in a pathway that coordinates expression of ribosomal protein 
genes with Pol III transcription.  
Work in this thesis demonstrates that Mediator regulates the chromatin 
structure of several regions characterized by silenced chromatin. Mediator 
mutations cause loss of heterochromatin at both telomeres and centromeres, 
which has implications for replicative aging and cell division. Our 
observation of chromosome segregation defects in med20∆ cells may also 
have more general implications. Chromosomal instability is a driving force in 
tumorigenesis and mutations in genes encoding Mediator subunits have been 
linked to the development of several forms of cancer. The thesis also 
introduces the unexpected finding that Mediator influences Pol III 
transcription. All together, our results support the view that Mediator does 
not only mediate signals from gene specific transcription factors to the Pol II 
transcription machinery. Instead Mediator is a multifaceted protein complex 
involved in many processes connected to transcription.   
Keywords: Mediator, transcription, heterochromatin, centromere, telomere, 
tRNA, exosome 
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SAMMANFATTNING PÅ SVENSKA 
Den genetiska informationen är lagrad i form av DNA i stora 
makromolekylära komplex kallade kromosomer. För att producera proteiner 
behöver de gener som återfinns i DNA läsas av och kopieras till budbärar-
RNA. Denna process kallas transkription och utförs av RNA polymeras II 
(Pol II). I våra celler finns ett stort antal faktorer, som styr 
transkriptionsprocessen, så att gener kommer till uttryck i rätt celltyp och vid 
rätt tidpunkt. Mediatorn är ett stort proteinkomplex som har som 
huvuduppgift att förmedla regulatoriska signaler från omgivningen till Pol II 
maskineriet. Mediatorn är evolutionärt konserverad från jäst till människa 
och består av 20 - 30 proteiner. Komplexet indelas traditionellt i fyra 
moduler: svans-, mitt-, huvud- och CDK8-modulen. Faktorer som kan 
stimulera transkription av en viss gen, s.k. aktivatorer, interagerar i första 
hand med svansmodulen medan huvudmodulen binder till Pol II. 
Konformationsförändringar i Mediatorn kan sedan överföra signaler från 
aktivatorer till Pol II-maskineriet. 
Det är viktigt att DNA inte skadas, då strängbrott och mutationer kan leda till 
sjukdom. För att skyddas, viras DNA runt ett proteinkomplex, innehållande 
åtta histonproteiner och formar på där med nukleosomer.  Nukleosom-
packning styr även uttrycket av gener. Det komplex som bildas av protein 
och DNA i cellkärnan kalls kromatin, där eukromatin är en lös 
sammansättning av nukleosomer, ofta associerad med hög 
transkriptionsaktivitet. Motsatsen, heterokromatin, är istället tätt packat och 
transkriptionellt tyst.  
På ändarna av kromosomerna finns telomerer som skyddar 
kromosomändarna från nedbrytning. I anslutning till telomererna finns s.k. 
subtelomera regioner, som är täckta av en transkriptionellt tyst 
heterokromatin-liknande struktur. Gränsen mellan heterokromatin och 
eukromatin måste bevaras för att inte ändra transkriptionsmönstret i de 
närliggande regionerna. Enzymerna Sir2 och Sas2 har motverkande 
aktiviteter och balansen mellan dessa bestämmer denna kromatingräns. I vår 
studie upptäckte vi att Mediator är involverad i regleringen av Sir2/Sas2 
balansen (Artikel I). Förlust av Mediatorsubenheten Med5 resulterade i ökad 
dominans av Sas2 vilket i sin tur ledde till ökad transkriptionell aktivitet i de 
subtelomera regionerna. Som en konsekvens av detta, minskade antalet 
livscykler som cellen totalt kunde genomgå.   
I centrum av kromosomen återfinns centromeren, fästpunkten för det 
maskineri, som reglerar kromosomsegregation under celldelning. Stora delar 
av centromeren är täckt av heterokromatin som är avgörande för dess 
  
funktion. Många faktorer är involverade i bildningen av detta heterokromatin 
och vi har funnit att Mediatorkomplexet är en viktig faktor i denna process 
(Artikel II). Utan Med20, en subenhet i Mediatorns huvudmodul, luckras 
heterokromatinet upp, vilket leder till ökad transkription i centromeren. 
Dessutom försvinner den centromerspecifika histonvarianten CENP-ACnp1 
från centromeren. Dessa förändringar stör normal kromosomsegregation 
under celldelning. Tidigare studier har visat att mutationer i ett maskineri, 
som behövs för s.k. RNA interferens (RNAi) ofta orsakar liknande 
kromosominstabilitet. Störningar i den RNAi-beroende mekanismen leder 
dock inte till förlust av CENP-A Cnp1 och Mediatorn fungerar därför troligen 
inte via denna process. 
Nivåerna av RNA i cellen styrs av balansen mellan bildning (främst 
transkription) och nedbrytning. Exosomen är en central del av RNA-
degradationsmaskineriet och detta enzymkomplex bryter ner RNA molekyler 
som är felaktiga eller inte längre behövs. Exosomen är bland annat 
involverad i degradation av RNA som bildas vid transkription av 
centromerer. Vi studerade därför vilken effekt förlust av exosomsubenheten 
Rrp6 har på nivåerna av de centromera transkript, som bildas vid förlust av 
Med20 (Artikel III). Våra studier visade att förlust av Rrp6 delvis kunde 
återställa den ökning av dessa transkript, som vi observerat när med20+ genen 
slogs ut. Genom att slå ut rrp6+ genen kunde vi även rädda den nedgång i 
heterokromatin vi hade observerat vid förlust av Med20. Trots dessa effekter 
på transkription och kromatin, påverkade Rrp6 inte den defekta 
kromosomsegregation vi observerade i avsaknad av Med20.  
Exosomen är också inblandad vid nedbrytning av felaktiga tRNA transkript, 
producerade av RNA polymeras III (Pol III) maskineriet. Vi fann en kraftig 
ökning av felaktiga tRNA molkyler i med20∆/rrp6∆, en jäststam som 
saknade generna för såväl Med20 som Rrp6 (Artikel IV). Resultatet var 
överraskande eftersom Mediatorn endast är känd som en regulator av Pol II-
beroende gener. Vidare undersökningar visade även på förhöjda nivåer av 
defekta 5S rRNA, snRNA och snoRNA transkript, även dessa producerade av 
Pol III. En noggrann analys av dessa RNA molekyler indikerade att förlust av 
Med20 orsakar defekt av transkriptionsterminering vid Pol III-beroende 
gener. De felaktiga transkripten hade dessutom en poly(A)-svans, vilket visar 
att de är märkta för Exosom-beroende degradation. I avsaknad av Rrp6 
stabiliseras dock dessa transkript, vilket gjorde det möjligt att observera 
effekter av Med20. Hur Mediatorn utövar sin effekt på Pol III-beroende 
transkription är fortfarande oklart, men vi har identifierat en oväntad funktion 
hos Mediator, som åter visar på hur funktionellt mångfacetterat detta viktiga 
komplex är.
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ABBREVIATIONS 
ABD 
ARE 
BRE 
CDK 
cnt 
CPSF 
CstF 
CTD 
DNA 
DSIF 
eIF 
EM 
ES 
GTF 
HAT 
HDAC 
IE 
imr 
Inr 
mRNA 
ncRNA 
NELF 
NPC 
otr 
P-TEFb 
PAZ 
PIC 
Activator binding domain 
AU-rich element 
TFIIB recognition element 
Cyclin dependent kinase 
Core centromere 
Cleavage and polyadenylation specific factor 
Cleavage-stimulating factor 
C-terminal domain of Pol II subunit Rbp1 
Deoxyribonucleic acid 
DRB sensitivity inducing factor 
Eukaryotic translation initiation factor 
Electron microscopy 
Embryonic stem cells 
General transcription factor 
Histone acetyltransferase 
Histone deacetylase 
Intermediate element 
Inner most repeats 
Initiator 
Messenger RNA 
Non-coding RNA 
Negative elongation factor 
Nuclear pore complex 
Outer repeats region 
Positive transcription elongation factor 
Piwi Argonaute Zwille 
Pre-initiation complex 
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II 
Pol II/III 
POM 
RDRP 
REST 
RISC 
RITS 
RNA 
RNAi 
RNP 
SEC 
siRNA 
SKI 
snoRNA 
snRNA 
ssRNA 
TAD 
TAF 
TAS 
TBP 
TF 
TGV 
TRAMP 
tRNA  
rRNA 
TSS 
UTR 
XLMR 
RNA Polymerase II/III 
Postnatal-onset microcephaly 
RNA dependent RNA polymerase 
RE1 silencing transcription factor 
RNA-induced silencing complex 
RNA-induced transcription silencing 
Ribonucleic acid 
RNA interference 
RNA-protein complex 
Super elongation complex 
Small interfering RNA 
Super killer 
Small nucleolar RNA 
Small nuclear RNA 
Single-stranded RNA 
Transactivation domain 
TBP associated factor 
Telomere-associated sequence 
TATA binding protein 
Transcription factor 
Transposition of the great vessels 
Trimeric Trf4/Trf5-Air1/Air2-Mtr4 polyadenylation complex 
Transfer RNA 
Ribosomal RNA 
Transcription start site 
Untranslated region 
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DEFINITIONS IN SHORT 
Activator Protein that increases transcription of a gene. 
Centromere Central chromosome region needed for 
chromosome separation during cell division. 
Chromatin loop A loop that allows for two separate chromosome 
regions to come into close proximity of each 
other. 
Elongation Transcriptional phase were RNA is synthesized. 
Endonuclease Enzyme that cleaves inside a transcript or DNA. 
Exonuclease Enzyme that digest transcript or DNA from the 
end. 
Initiation Transcriptional phase were PIC is assembled 
and RNA polymerase initiate transcription. 
Kinetochore Multiprotein complex, which connects the 
centromere and microtubules during cell 
division. 
Mediator Multiprotein complex that regulates 
transcription. 
Mitosis Cell cycle phase were the cell divides. 
Polyadenylation Process that adds a poly(A)-tail to transcripts. 
Promoter proximal stalling Pausing of Pol II after promoter clearance. 
Repressor Protein that decreases transcription of a gene. 
RNAi Machinery that digests RNA with the help of 
small RNA molecules. 
Splicing Removal of introns from pre-RNA transcripts 
Telomeres Structures at chromosome ends. 
Termination Transcriptional phase where the transcript is 
released from Pol II, which dissociates from the 
template. 
The exosome A RNA degradation complex. 
Transcription Process that copies DNA into RNA molecules. 
Translation Process that reads the RNA and produces 
proteins. 
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1 INTRODUCTION 
DNA is the genetic blueprint for our cells. RNA polymerases copy DNA 
sequences into RNA through a process called transcription. Transcripts of 
protein-coding genes are denoted messenger RNA (mRNA) and they carry 
the genetic information to the ribosome where protein production 
(translation) takes place. In most eukaryotes, nuclear transcription depends on 
three distinct polymerases: RNA polymerase I (Pol I) produces ribosomal 
RNA (rRNA) used as parts of the ribosome (1), RNA polymerases II (Pol II) 
is responsible for production of mRNA and non-coding RNA (ncRNA) 
molecules (2), whereas RNA polymerase III (Pol III) primarily produces 
transfer RNA (tRNA) and some rRNA (3). 
1.1 Basic transcription 
The functional unit of inheritance is the gene. A gene corresponds to a DNA 
sequence that provides information for RNA synthesis. Apart from the actual 
transcribed sequence there are a number of regulatory elements that control 
gene transcription. The promoter defines where the RNA polymerase should 
initiate transcription. There is considerable variation in promoter sequences, 
also between genes transcribed by the same polymerase.  
A classical DNA sequence element found in Pol II dependent promoters is 
the TATA-box (Figure 1), which is located about 30 bp upstream of the 
transcription start site (TSS) at about one fifth of all promoters (4). 
TSS DownstreamUpstream
TATABRE
-30 +1-35
TFIIB
Promoter Gene
TBP TAFsTFIID
Inr Exon Intron Terminator
DownstreamUpstream Gene
Enhancer
Activator
Silencer
Repressor
Enhancer
Activator
Silencer
Repressor
Figure 1. Schematic presentation of a Pol II dependent gene structure. 
The different sequence elements are discussed in the text. 
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At some promoters, the TATA-box is flanked by the TFIIB recognition 
element (BRE), which may have either a positive or a negative impact on 
transcription of the associated gene (5). The most commonly occurring 
promoter motif is the initiator (Inr), which centers on the TSS (4).  
Pol II cannot recognize promoter elements by itself, but needs the help of a 
set of additional general transcription factors (GTFs: TFIIA, B, D, E, F, and 
H). These factors assemble together with Pol II on the promoter and form the 
pre-initiation complex (PIC) (Figure 2)(6, 7).  
Promoter Gene
A
B
C
D
E
F
TFIIA
TFIIE
TFIIH
RNATFIIF
TFIIB
RNA Polymerase II
Mediator
Activator
TFIID
Nucleosome
Figure 2. Initiation of Pol II transcription 
A model describing the different steps in Pol II dependent initiation. A) Mediator (see 1.3) 
is initially recruited to the promoter via activator interactions. B) Mediator helps to recruit 
TFIID to the TATA-box and Inr. TBP creates a sharp bend in the DNA. C) TFIIA stabilizes 
the TFIID-DNA interaction. Subsequently, TFIIB enters the complex and interacts with 
BRE. D) Pol II is recruited in complex with TFIIF. E) TFIIE and TFIIH enter and complete 
PIC formation. TFIIH unwinds the promoter and allows access for Pol II to the template. F) 
Pol II is released in complex with TFIIF. Mediator, TFIID, TFIIA, TFIIE, and TFIIH 
remain bound at the promoter and facilitate re-initiation and further rounds of transcription.  
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According to the classical model of Pol II transcription initiation, the process 
is initiated by TFIID, which consists of the TATA-binding protein (TBP) in 
complex with a set of TBP-associated factors (TAFs). TBP recognizes the 
TATA-box whereas the TAFs interact with the Inr. TBP binding introduces a 
sharp bend in the promoter DNA, which enables TFIIA to bind upstream of 
TFIID. In the next step, TFIIB can interact with both TBP and DNA 
surrounding TATA-box, for instance the BRE, and thereby stabilizing the 
TBP-TFIIB-TFIIA-DNA complex (8, 9). In turn TFIIB recruits Pol II in 
association with TFIIF (10). Finally TFIIE and TFIIH are recruited which 
enables transcriptional initiation (11). 
After release from the promoter Pol II transcribes the gene, which in most 
cases contains both protein-coding sequences called exons and non-protein-
coding sequences termed introns (12). At a terminator site, transcription ends 
by cleavage of the nascent RNA and subsequent release of Pol II (13). 
Genes are present in the context of chromatin. Chromatin is the state of DNA 
packaging in the nucleus and it is formed by protein-DNA units called 
nucleosomes (14). They consist of a core of histone proteins wrapped by 
DNA. While the nucleosomes can protect the genetic material it may also 
prevent Pol II from accessing DNA and initiate transcription (15). A 
transcription factor’s affinity for its binding site is dependent on the precise 
nucleosome configuration (16).  The chromatin structure is regulated by 
histone modifications (e.g. acetylation or methylation) or changes in the 
composition and position of nucleosomes by chromatin remodeling enzymes 
(17). 
Regulatory proteins, referred to as activators and repressors, associate with 
specific DNA elements (enhancers resp. silencers) and control the frequency 
of transcription at specific genes. Activators can help recruit the transcription 
machinery and stimulate assembly of PIC (18). These regulatory proteins can 
also affect transcriptional activity by modifying the chromatin structure. In 
most cases, interactions between activators and the general transcription 
factors are not direct, but instead mediated by a large multiprotein complex 
called the Mediator (19). This thesis explores the role of Mediator in 
chromatin formation and transcriptional regulation of non-coding RNAs.  
1.2 RNA Polymerase II 
1.2.1 Structure 
At its core, Pol II consists of 12 subunits, denoted Rpb1 to Rpb12 (20). The 
subunits are highly conserved and their sizes usually vary between 6 and 200 
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kDa. Rpb1 is the largest subunit and together with Rpb2 it forms the opposite 
sides of a “cleft” through which the DNA template can travel to reach the 
active site (21). Rpb1 includes a mobile “clamp”, which shifts from an open 
to a closed state when Pol II transitions into elongation (22). When closed, 
the clamp locks the RNA-DNA hybrid in place during transcription and at the 
bottom of the cleft is a channel, which enables new nucleotides to enter and 
the nascent RNA to exit.  
Rpb1 also contains a C-Terminal Domain (CTD), which consists of tandem 
repeats of the heptapeptide sequence YSPTSPS (23). The CTD functions as a 
binding site for a number of other factors required during transcription and 
for correct processing of the primary transcript (24-27). The phosphorylation 
status of the CTD governs interactions with these factors and thereby helps to 
coordinate the different steps in mRNA formation, including transcription 
initiation, elongation, termination and post-transcriptional processing. The 
CTD heptapeptide repeats are modified at different sites. For instance, serine 
2 and 5 phosphorylation (Ser2-P, Ser5-P) regulate transition from initiation to 
elongation, but also have further functions (27).  
The other Pol II subunits are needed for structural and regulatory purposes. 
Rpb3 together with Rpb5 connects to a majority of the other subunits and 
constitutes the structural core of Pol II (28). During Pol II assembly Rpb3 
together with Rpb11 forms a platform, which enables Rpb1 and Rpb2 to 
assemble (29). Rpb4 and Rpb7 differ from the other Pol II subunits, since 
they form a sub-complex not always associated with the core complex (30). 
Interestingly, deletion of the RPB4 gene in yeast results in a viable but 
temperature sensitive phenotype. The Rpb4/Rpb7 dimer has mostly been 
linked to regulation of stress responses, but more recent findings connect it to 
processes such as DNA repair, mRNA export, mRNA decay, and translation 
(30). Rpb6 is found close to the ”clamp” and is believed to influence the 
positioning of this structure (31).  
Four of the Pol II subunits, Rpb5, Rpb6, Rpb8, and Rpb10, can also be found 
in Pol I and Pol III, suggesting that these subunits are involved in 
mechanisms common to all three polymerases (31, 32). 
1.2.2 Initiation 
After the assembly of PIC has been completed the two strands of the 
promoter DNA needs to be separated in order for Pol II to access the template 
sequence. The ATPase/helicase activity of TFIIH melts the DNA close to the 
TSS (33). An initial transcription bubble is formed between base -9 and +2 
relative to TSS (34). The bubble is stabilized by TFIIB and TFIIE (35). 
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Access to the single stranded template enables Pol II to begin transcribing a 
short stretch of RNA. The initial transcription bubble is unstable and after a 
short progression of Pol II, the upstream bubble collapses (36). At this point 
the polymerase has cleared the promoter and it no longer requires the helicase 
activity of TFIIH to progress. A part of TFIIB can enter the channel in which 
the nascent RNA exits and block the active site. Promoter escape, i.e. the 
transition to the elongation phase, can thus be regulated by TFIIB. 
During promoter escape, Ser5 of the CTD is phosphorylated by TFIIH (37). 
Before Pol II can engage in subsequent rounds of transcription the CTD 
needs to be dephosphorylated (38). After the transcription of the first four 
nucleotides, conformational changes occur in Pol II that commit the 
polymerase for further elongation (39). During promoter escape TFIIB, 
TFIIF, and Pol II dissociate from the rest of the PIC (40). The other factors, 
TFIIA, TFIID, TFIIE, TFIIH, and Mediator, still remain at the promoter and 
help to facilitate re-initiation of additional rounds of transcription.  
1.2.3 Elongation 
Pol II activity is also regulated after it has cleared the promoter. Pol II often 
stalls about 50 nucleotides from the TSS (41). Pausing of Pol II is a rate-
limiting event during transcription, which allows for more precise expression 
timing and regulation of transcript levels. For example, promoter-proximal 
stalling is observed at many genes involved in differentiation and genes that 
require signal stimulation (42). The molecular mechanisms for stalling of Pol 
II are still unclear. However there are indications that part of the capping 
machinery (see 1.6.2) is involved (43). In fact, at many mRNA genes the 
polymerase is paused at the capping checkpoint (44, 45). The checkpoint 
coincides with the 5ʹ′-end of the nascent RNA emerging from the Pol II exit 
channel. At this point a 7-methyl guanosine is added to the 5ʹ′-end of the 
RNA via a 5ʹ′-5ʹ′ triphosphate bridge (46).  
Pausing is promoted by two factors, DSIF (DRB sensitivity inducing factor) 
and NELF (Negative elongation factor) (Figure 3) (47). Gdown1, a 
substochiometric subunit of Pol II, can further enhance NELF/DSIF induced 
stalling (48). Pol II remains paused until P-TEFb (Positive transcription 
elongation factor) phosphorylates several targets, including Ser2 of the CTD, 
as well as NELF and DSIF (49). Paused Pol II is then released and 
phosphorylation also causes DSIF to dissociate from NELF and instead 
accompany Pol II during elongation.  
One major obstacle for Pol II to overcome during transcription is the 
nucleosome. As Pol II progresses through the gene it needs to disassemble 
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the nucleosomes in front of it to access the DNA template. Several elongation 
factors are required for progression through the nucleosome environment 
(45). ATP-dependent chromatin remodeler factors can modify the 
nucleosome-DNA interaction and thus promote elongation (50). For instance, 
the histone chaperone complex FACT facilitates Pol II access to DNA (15). 
Another example is the histone chaperone Spt6 that binds to phosphorylated 
Ser2 of the CTD and promotes elongation (51). To maintain the chromatin 
structure at the transcribed gene, nucleosomes need to be reassembled behind 
the elongating polymerase. As Pol II progresses through the gene, it 
continuously bends the template 90°. It has been proposed that this bend 
brings the upstream and downstream DNA into close proximity, which in 
turn, enables the polymerase to transfer the nucleosome to its original 
position (52). 
 
 
1.2.4 Termination 
Termination is one of the least understood processes of Pol II transcription 
(13). Each transcribed gene needs a clear termination signal, indicating where 
the RNA polymerase should end transcription. For most mRNA genes the 
RNA Polymerase II
NELF
A C
B D
DSIF
Nucleosome
RNA
P-TEFb
Promoter proximal stalling
Phosphorylation of DSIF, NELF and CTD
Elongation
Promoter clearance
PIC
Figure 3. Promoter proximal stalling and transcriptional elongation 
A) Pol II transcription is initiated. B) NELF and DSIF are recruited and Pol II stalls after 
synthesis of ∼50 nt of RNA. C) P-TEFb phosphorylates NELF, DSIF, and CTD. D) Pol II 
escapes from stalling and continues elongation in complex with P-TEFb and DSIF, 
whereas NELF leave the template. 
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termination signal is a stretch of A’s at the 3ʹ′ end of a gene (13). The 
consensus sequence AAUAAA together with a G/U-rich downstream 
element on the nascent RNA constitutes the termination signal. Current 
theories suggest that Pol II pauses upon reaching the AAUAAA signal, which 
is recognized by the CPSF (cleavage and polyadenylation specific factor) 
subunit CPSF160 (Figure 4) (53). The cleavage-stimulating factor (CstF) is 
recruited to the G/U rich downstream domain, and binds to the CTD and 
CPSF, thus disrupting the interaction between CPSF and the Pol II body (54). 
The complex of CstF, CPSF and CFIIm (Cleavage Factor II) instead 
associates with the CTD and allows the CPSF subunit CPSF73 to cleave the 
nascent transcript at a CA-sequence (53, 54). The termination process at 
histone genes differs from other protein-coding genes in that the nascent 
RNA at the end of the gene forms a stem loop that is recognized by the U7 
small nuclear ribonucleoprotein (snRNP) (55). This enables CPSF73 
mediated cleavage of the RNA and rapid release of Pol II from the histone 
gene. At non-histone mRNA genes, Pol II can instead progress several 
kilobases downstream of the cleavage site before dissociation from DNA 
(56). 
 
RNA Polymerase II
CPSF
A) CPSF binding and Pausing of Pol II
B) CPSF capture the nascent RNA
C) CPSF forms a complex with CstF and CFIIm
D) CPSF cleaves the RNA
CstF
RNA
CFIIm
Figure 4. Transcriptional termination at Pol II dependent genes. 
A) CPSF binds to elongating Pol II. B) CPSF captures the transcript by binding to the 
AAUAAA signal on the nascent RNA. C) CstF is recruited to downstream G/U rich element. 
CstF also interacts with CPSF and disrupts CPSF’s interaction with the Pol II body. Instead 
CPSF, CstF and CFIIm form a complex that interacts with CTD. D) CPSF cleaves the nascent 
RNA and Pol II continues to transcribe for a short distance before it falls off the template DNA.   
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Exactly how Pol II is released from the DNA template is still not clear, but 
there are observations that clarify parts of the process. First, the Pol II 
elongation complex slows down or pauses at the end of the gene (57). This 
enables the exchange of Pol II associated elongation factors for transcription 
termination factors (58). Another release mechanism involves destabilization 
of the RNA-DNA hybrid, thus facilitating dissociation of Pol II from the 
template. In E. Coli, the termination factor Rho invades the main channel and 
either uses its helicase activity or sterically interferes with the polymerase to 
cause melting of the RNA/DNA hybrid (59). Although there are no known 
Rho homologues in eukaryotes, the 5ʹ′-3ʹ′ exonuclease, Rat1 and the Sen1 
(essential super family I helicase) proteins in Saccharomyces cerevisiae, act 
as termination factors and have been suggested to work through a Rho-like 
mechanism (60). These two factors have been shown to cooperate and induce 
transcriptional termination (61). 
Termination of transcription at non-coding genes differs from that of protein-
coding genes. In S. cerevisiae for instance, the termination sequence at 
snoRNA genes includes the two motifs UCUU and GUA(A/G) (62). Two 
proteins bind to these motifs, Nab3p (nuclear poly(A) RNA binding 3) and 
Nrd1 (nuclear pre-mRNA down regulation 1) respectively. Nrd1, Nab3, and 
Sen1 form a complex, which can bind to Ser5-P and Ser2-P of the CTD (63). 
Sen1 is believed to utilize its ATP-dependent helicase activity to disrupt the 
elongation complex and thus induce termination (64). The Nrd1/Nab3/Sen1 
complex can physically interact with the TRAMP-exosome complex (see 
1.6.1) to enable further 3ʹ′-processing. 
1.3 The Mediator Complex  
The Mediator complex is a multiprotein complex involved in a wide variety 
of transcriptional processes. Its main function is to transfer regulatory signals 
from activators and repressors to the Pol II machinery. Originally, it was 
discovered as an activity that mediates activator dependent regulation of Pol 
II in S. cerevisiae (65, 66).  Before the discovery of Mediator it was believed 
that activators and repressors primarily functioned via direct interactions with 
the Pol II machinery (67, 68). However, in a reconstituted Pol II in vitro 
transcription system with partially purified proteins, these activators were not 
able to stimulate transcription unless a fraction containing a so-called 
mediator of activation was added (65).  In parallel, four subunits (Srb2, Srb4, 
Srb5, Srb6) of a larger complex were discovered to suppress Pol II CTD 
activity and were thus named the suppressor of RNA polymerase B (Srb) 
(69). It was later discovered that they in fact were subunits of the Mediator 
complex (70). 
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Mediator was subsequently purified to homogeneity and demonstrated to be 
part of a holoenzyme, made up of the core polymerase and the Mediator 
complex (70). Many of the Mediator subunits are encoded by genes that had 
previously been identified in genetics screens as factors involved in 
activation and repression of transcription (71). The connection to these 
previous genetic studies demonstrated the relevance of Mediator in vivo. 
Later, structural analysis showed that there were several contact points 
through which Mediator could influence the activity of Pol II (72-76).  
1.3.1 Structure 
The Mediator complex is conserved from yeast to humans (77). The number 
of subunits differs between species, from about 20 to 30. Mediator is perhaps 
best characterized in S. cerevisiae where it contains 25 subunits (78). The 
budding yeast Mediator is subdivided into four submodules termed the tail, 
middle, head, and CDK8 module (Figure 5). The structure of Mediator has 
been extensively studied, but its size, flexibility and heterogeneity have made 
it difficult to obtain a high-resolution structure of the entire complex. There 
is, however, low-resolution electron microscopy (EM) 3D structure data 
available for the entire Mediator complex (75, 79). In addition, several 
subunits have been studied by X-ray crystallography, either alone or in 
subcomplexes with other Mediator components (80-83). The Pol II 
interacting head module is the best characterized while the structure of the 
tail module is still poorly understood (78). Many of the subcomplexes are 
functional units that are connected to Mediator through flexible linkers (84, 
85).  
Tail module 
Many activators and repressors interact with Mediator via the tail module. 
The proteins comprising this module in S. cerevisiae are Med2, Med3, Med5, 
Med14, Med15, and Med16 (86). The genes encoding these proteins are non-
essential, but when they are deleted in combination lead to a lethal 
phenotype. The Med16 protein functions as the bridge between the tail 
module and the Mediator middle module. Interestingly, in cells lacking 
Med16, the tail module can assemble and exert its function as a separate 
entity and for instance be recruited by the Gcn4 activator protein to 
promoters (87). Interestingly, even if loss of Med16 prevents recruitment of 
the middle and head modules of Mediator, the presence of the isolated tail 
module is enough to attract TBP and Pol II, and to stimulate transcription of 
the ARG1 gene. In fact, recruitment of the tail module on its own resulted in 
higher activation of ARG1 gene transcription than recruitment of an intact 
Mediator. 
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The tail module subunits contain several activator-binding domains (ABDs), 
which interact with the transactivation domains (TAD) of activators (88-91). 
ABDs are found in many different Mediator subunits and individual subunits 
may contain more than one ABD. Although each individual ABD-TAD 
interaction can be weak, many cooperative-binding surfaces stabilize the 
Mediator-activator interaction (82, 89). For instance, the activator Gcn4p 
interacts with Med2, Med3, Med15, and Med16 (87, 92). The involvement of 
multiple ABDs creates very diverse and complex interaction surface between 
Mediator and activators. Even if the structures of the different ABDs are 
diverse, the same TAD can bind to more than one ABD. Studies have 
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Srb5
Srb2
Srb6
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Pmc5
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Pmc6
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hMed6
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HSPC296
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p28b
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MED14
MED15
MED16
S.c.
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Pgd1
Nut1
Rgr1
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Nut2
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MED12
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CycC
S.c.
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Trap240
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Srb11
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Cyclin C
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MED19
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MED14
S.c.
Rgr1
S.p.
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H.s.
TRAP170
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In human only
MED12L CDK8
MED13L CDK8
MED23 Tail
MED24 Tail
MED25 N/A
MED26 N/A
MED27 Tail
MED28 N/A
MED29 Tail
MED30  N/A
Figure 5. The Mediator modules 
Schematic representation of Mediator, showing the different modules with the corresponding 
subunits in S. cerevisiae, S. pombe, and human cells. N/A indicates subunits with unassigned 
module affiliation. 
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demonstrated that in their free states, the TADs may be unstructured. 
However, when a TAD comes into contact with an ABD it adjusts its 
structure to fit the interacting domain (89). The flexibility of TAD structures 
allows for different interactions with Mediator. The absence of a single TAD-
ABD conformation has led others to term the interaction between the 
activator Gal4 and Mediator subunits for a ’fuzzy’ complex, to reflect the 
flexibility of the TAD-ABD interaction (82).  
The binding of an activator to a Mediator subunit results in conformational 
changes in the entire complex. The conformational changes differ depending 
on the type of activator-Mediator interaction (93, 94). Mediator can thus 
assume a conformational state specific for the activator and the gene it 
regulates, which may contribute to Mediator’s ability to regulate a very 
diverse set of genes.  
Middle module 
In S. cerevisiae, the middle module contains four essential subunits (Med4, 
Med7, Med10 and Med21) and three non-essential subunits (Med1, Med9 
and Med31) (95). Due to the flexible nature of the middle module it has been 
difficult to obtain a detailed 3D-structure. However, structures of several 
subcomplexes have been reported (81, 84, 95). The C-terminal part of Med7 
interacts with Med21 and forms a flexible hinge (81). Modeling of the 
Med4/Med9 heterodimer led to the conclusion that this complex may harbor 
a similar hinge and together with the Med7/Med21 dimer form the backbone 
of the middle module (95). The Med7/Med21 and Med4/Med9 hinges could 
play an important role in the transfer of activator induced conformational 
changes to the rest of the Mediator complex (81).  
The non-essential Med1 subunit has been implicated in regulation of the 
CDK8 module (96). This module contains a cyclin dependent kinase-cyclin 
pair (Cdk8 - CycC), which interacts with Med1 and Med4 (97, 98). In 
humans MED1 interacts with a number of activators, including nuclear 
hormone receptors, and assists in the recruitment of Mediator to promoters 
under their control (99, 100). Med19 has been placed at the boundary 
between the middle and head module (101). Interestingly, loss of Med19 
results in loss of the middle module and leads to the formation of a stable 
Mediator complex containing only the tail and head module. Loss of the 
middle module does however remove Mediator’s ability to regulate 
transcription through activator-Mediator-Pol II interaction. 
Head module 
The head module harbors the conserved subunits Med6, Med8, Med11, 
Med17, Med18, Med20, and Med22. The structure of this module has been 
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carefully studied with X-ray crystallography (102, 103). A comparison 
between the Schizosaccharomcyes pombe and S. cerevisiae head modules 
demonstrated high structural conservation despite only 15 % sequence 
conservation (103).  
Med17 is the largest of the head module subunits (103). It spans a sizeable 
portion of the module and interacts with the majority of the subunits. The 
non-essential subunits Med18 and Med20 form a mobile subcomplex with 
Med20 being the most peripheral subunit. In fission yeast, loss of Med18 
results in dissociation of Med20 from the rest of the complex, while deletion 
of the med20+ gene does not have an impact on Med18-Mediator interaction 
(104). Med8p tethers the Med18p/Med20p complex to the head module 
(103). The head module has been described as a jaw-like structure, with 
mainly Med17 constituting a fixed upper jaw and Med18/Med20 functioning 
as a flexible lower jaw (103).  
TBP appears to interact with several subunits of the head module (105). The 
jaw of the head module is closed when Mediator is not associated with TBP. 
After TBP contacts the head module the jaws opens, allowing for interaction 
with Pol II. The Pol II subcomplex Rpb4/Rpb7 binds between the two jaws in 
the open conformation and can interact with Med18 and Med20. The head 
module also connects to Pol II via a direct physical interaction between Rpb3 
and Med17 (76).  
The structure of the head module has been determined in complex with the 
CTD, which primarily interacts with Med6, Med8, and Med17 (102). The 
Mediator head module specifically associates with dephosphorylated CTD. 
During transition from transcriptional initiation into elongation the CTD is 
phosphorylated at Ser2 and Ser5 (37, 49). Phosphorylation of these residues 
significantly reduces the affinity of CTD for the head module (102). This can 
explain how Pol II can separate from the Mediator complex when Pol II 
transitions into the elongation phase.  The head module not only binds to the 
polymerase but can also interact with the general transcription factors TFIIB, 
TFIIH and TBP, further demonstrating the central role of this Mediator 
region (80, 97, 106).  
CDK8 module  
The CDK8 module differs from the head, middle and tail module in that it is 
only intermittently associated with the core complex. The module is 
composed of Med12, Med13, CycC, and Cdk8 (107). The CDK8 module has 
been described as a repressor of Mediator-Pol II interaction. The actual 
mechanism of how this occurs is still under debate and could even differ 
between species. Studies of human Mediator suggest that the binding of the 
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CDK8 module to core Mediator results in conformational changes that 
disrupt Mediator-Pol II interactions (108). In contrast, the CDK8 module in 
S. pombe competes with Pol II for access to the core Mediator (109). Med12 
and Med13 are two of the biggest subunits of the Mediator complex. They 
are the basis for the assembly and stability of the CDK8 module (73, 107). 
Med13 contains a ‘hook’ domain that connects to a ‘hook’ structure of the 
Mediator tail module (73). Med12 constitutes the central bulk of the module 
and connects with both Med13 and CycC. In turn, CycC bridges between 
Med12 and Cdk8. The Med13 domain that binds to Med12 is flexible and 
provides freedom of movement for the rest of the CDK8 module (107). 
Cdk8 may also block transcription via alternative mechanisms. A recent 
report demonstrated that the CDK8 module could regulate the stability of the 
Mediator tail module by phosphorylating Med3 (110). The phosphorylation 
in turn triggers ubiquitylation and subsequent degradation of the Med3 
protein. This mechanism would allow Cdk8 to repress transcription by 
simply removing subunits interacting with activators, from the Mediator 
complex.   
Even though the CDK8 module has primarily been associated with repression 
of transcription, the module also plays a role in gene activation. CDK8 
module binding to the Mediator tail module results in an open conformation 
of Mediator and induction of holoenzyme formation (107). The flexibility of 
the Mediator-CDK8 module interaction may allow the CDK8 module to 
associate with the back of the Mediator complex (73). Even in this case the 
dominant connecting subunit is Med13, which tethers the CDK8 module to 
the tail while Cdk8 interacts with the back of the middle module. It appears 
that Cdk8 association with the middle module can block a binding site for the 
CTD and thereby interfere with Pol II recruitment.  
1.3.2 Mediator and transcriptional initiation 
Mediator has been shown to regulate most Pol II transcribed genes in S. 
cerevisiae. It can function in both an activating and a repressing capacity 
(Figure 6)  (19, 111). The role of Mediator has been the target of extensive 
research, but the complexity of transcriptional initiation leaves much more to 
be discovered. According to the general model, activators bind to enhancer 
regions and then recruit Mediator (112, 113). In the next step, the complex 
helps to recruit and assemble the GTFs and Pol II at the promoter, leading to 
initiation of transcription (19). Evidence that Mediator is recruited before the 
GTFs has been obtained in Drosophila melanogaster. Upon heat shock, the 
activator HSF and Mediator are recruited without the GTFs or Pol II (114). 
Mediator and its role in non-coding RNA and chromatin regulation  
14 
In S. cerevisiae, Mediator is recruited to the HO promoter at the end of 
mitosis with the help of transcription factor SBF (115). Pol II and GTF 
however are not recruited until late in G1-phase.  
Mediator interaction with general transcription factors 
Mediator helps to stabilize the GTFs at the promoter and physically interacts 
with e.g. TBP, TFIIE and TFIIH, which stimulates transcription initiation and 
facilitates reinitiation of transcription (80, 116-118). Mediator stimulates 
TFIIB recruitment to promoters in vitro and higher TFIIB concentrations are 
required for transcription initiation in the absence of Mediator (119). 
Mediator also helps to regulate the enzymatic activity of the GTFs. In support 
of this notion, the Mediator subunit Med11 is important for the recruitment of 
TFIIH (116). Depending on the specific MED11 mutation, the outcome may 
be very different. While some mutations inhibited TFIIH recruitment, others 
resulted in normal recruitment of TFIIH, but reduced Pol II recruitment. Yet 
another MED11 mutation impaired the function of a TFIIH submodule 
TFIIK, which is responsible for phosphorylation of CTD. In conclusion, 
Mediator does not only affect the recruitment of TFIIH, but it also regulates 
its enzymatic activity. 
Mediator as an activator 
Many activators interact with the Mediator tail module and in S. cerevisiae 
the Med2, Med3, and Med15 proteins play a central role for these 
Activator Repressor
Enhancer
CDK8 moduleA B
Silen
cer
Mediator
RNA Polymerase II
PIC
Gene
Gene
Figure 6. Mediator transduces signals from activators and repressors to the basal 
Pol II transcription machinery at the promoter. 
A) Mediator is recruited by activators bound at enhancer elements and stimulates 
assembly of the Pol II transcription machinery. B) Repressors bind to silencer elements 
and inhibit assembly of the transcription machinery. This effect can for instance be due 
to a stabilization of CDK8 module interactions with the rest of Mediator. 
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interactions (120). Loss of these subunits cripples the direct interaction 
between Mediator and the activator proteins. Further evidence for tail module 
dependent recruitment comes from studies of a med16Δ mutant strain. As 
noted above (see 1.3.1), loss of this subunit leads to the formation of a free 
tail module, which can be recruited by activators as a separate entity (87). 
MED15 is an important point of interaction for activators in both human and 
Caenorhabditis elegans (121, 122). In metazoan cells, MED29 and MED27 
replace Med2 and Med3, but the function of these proteins for activator 
interactions is still unclear (77).  
Activators that function via the tail module often regulate inducible genes, 
whereas constitutively active genes often are tail module independent (123, 
124). While the tail module dependent genes often have a TATA-box 
element, the independent genes instead require TFIID (124). This is however 
not a general rule, since there are many examples of activators that interact 
with the head or middle module that regulate inducible genes. In metazoans, 
for instance, MED1 of the middle module is required for activation of nuclear 
hormone (NR) receptor genes (125, 126). MED1 contains an NR recognition 
motif (LxxLL) that interacts with the AF2 domain of the NR, which in turn 
leads to recruitment of the entire Mediator complex. (127). 
Most studies link the CDK8 module to transcriptional repression and 
transcriptional inhibition of activator dependent genes (128). In mammals, 
CDK8 associates with inactive transcription complexes and disengages once 
a gene is activated (129). As another example, in S. cerevisiae Cdk8 
dependent phosphorylation of Med2 causes repression at specific genes 
(128). There are however many examples of the opposite. In yeast, the CDK8 
module is needed for Mediator dependent activation of the GAL1 gene (130). 
At the GAL1 promoter CDK8 module helps to facilitate TBP association. 
Furthermore, CDK8 in human cells is essential for activation of thyroid 
hormone-dependent transcription and for recruitment of Pol II to the 
promoters of the regulated genes (131). 
1.3.3 Mediator and transcriptional elongation 
Mediator may interact not only with the promoter region, but also with the 
gene body (132). The role of Mediator at these positions is not fully 
understood. As noted above (see 1.2.3), Pol II is paused at a promoter 
proximal position in D. melanogaster heat shock genes (114). Upon heat 
chock, Mediator is recruited to these genes, leading to Pol II release. A role 
for Mediator in Pol II release is further supported by studies in mural 
embryonic stem (ES) cells, were deletion of Med23 abolished Mediator 
recruitment to the Egr1 gene and prevented Pol II release from its stalled 
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position (133). Mediator may in part function via the NELF/DSIF enhancing 
protein, Gdown1. This protein functionally interacts with Mediator, which 
can alleviate Gdown1 induced Pol II inhibition in vitro (48, 134, 135). 
Yet another link to transcription elongation was provided by the observation 
that Mediator helps to recruit the super elongation complex (SEC) (136). 
SEC contains a number of Pol II transcription elongation factors, including P-
TEFb, a cyclin dependent kinase that can phosphorylate DSIF, NELF and 
CTD, and thereby stimulate the transition from promoter proximal pausing to 
productive Pol II transcription (see 1.2.3) (49). Components of SEC can 
copurify with MED26 due to the interaction between the MED26 N-terminal 
domain (NTD) and the SEC component EAF (136). Interestingly, domains 
that are similar to MED26-NTD are found in other elongation factors, 
including TFIIS, Elongin A and IWS1 (137). Apart from interacting with 
SEC, MED26 also interacts with TFIID suggesting that this Mediator subunit 
is important for the transition from transcription initiation to elongation 
(136).  
Another Mediator subunit that has been linked to transcription elongation is 
mammalian CDK8. Interestingly, CDK8 and MED26 are not present in the 
Mediator complex simultaneously (138). These two mutually exclusive 
factors appear to affect transcription elongation in distinct ways. CDK8 
interacts with P-TEFb and is important for P-TEFb recruitment to genes with 
paused Pol II (139). Knockdown of CDK8 did not however affect the release 
of paused Pol II. This would implicate CDK8 involvement in the effective 
localization of P-TEFb to genes with paused Pol II, but not P-TEFb 
dependent Pol II release. Other examples of genes where CDK8 has been 
suggested to regulate transcription elongation are the thyroid receptor 
induced genes and hypoxia response genes (131, 140). 
Mediator can, apart from recruiting elongation factors, influence elongation 
by affecting chromatin structure. One obstacle for Pol II during transition 
from initiation to elongation is the +1 nucleosome. Mediator has been shown 
to collaborate with TFIIS to induce changes in the catalytic properties of Pol 
II, in order to facilitate polymerase clearance of the +1 nucleosome (141). 
1.3.4 Mediator and transcriptional termination 
Recent evidence has implicated Mediator in regulation of transcription 
termination (142). Mediator has been found at the 3ʹ′-end of genes (132, 143). 
In S. cerevisiae, Mediator helps to recruit the termination factors CF1 
(cleavage factor 1) and CPF (cleavage and polyadenylation factor) to the 3ʹ′-
end of the INO1 and CHA1 genes (142, 144). Loss of the Mediator head 
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module subunit, Med18, results in loss of CF1 and CPF from the termination 
site. As a consequence transcription termination fails and Pol II reads through 
the termination site.  
In order to maintain high frequency transcription of certain genes, there is a 
need for efficient re-initiation. To facilitate re-initiation, the promoter and 
termination sites can connect through the formation of a chromatin loop 
(144). At the INO1 and CHA1 genes, TFIIB, promotes gene looping and 
juxtapositioning of the promoter and termination sites (144). Mutations in 
TFIIB cause disassociation of the promoter and termination sites, and abolish 
Mediator localization to the end of the transcribed region. Similarly if 
MED18 is deleted the connection between promoter and termination regions 
is lost. TFIIB mutations and loss of Med18 both cause a depletion of CF1 and 
CPF at the 3ʹ′-end of genes. These observations suggest that the head module 
of Mediator is crucial for the communication between the promoter and 
termination sites. Since the head module also interacts with Pol II, it is 
possible that Mediator dependent association between the promoter and 
termination sites helps to reinitiate Pol II after transcriptional termination 
(145). This mechanism would ensure fast and reliable re-initiation of 
transcription, allowing Pol II to transcribe the same gene multiple times. 
1.3.5 Mediator and Chromatin 
The composition and organization of chromatin is of utmost importance for 
transcriptional activity. Mediator has been shown to influence a large number 
of chromatin related processes, including the composition and modification 
of single nucleosomes as well as the 3D organization and positioning of 
chromosomes. Mediator occupancy also correlates with specific histone 
modifications and the complex can interact directly with nucleosomes (146, 
147). 
Chromatin organization 
In the nucleus, the 3D-organization of genomic DNA is very important for 
the control of gene expression. Mediator has been found to influence many 
levels of this organization (144, 148, 149). As previously mentioned, 
Mediator can help to juxtapose the promoter and transcription termination 
site of a gene (see 1.3.4)(144). This is accomplished by the formation of a 
gene loop that brings two distant regions into close proximity. In order for 
Mediator to transduce the signal of an activator to the Pol II machinery it 
needs to close the gap between these factors. Enhancer regions that activators 
bind to can be at a considerable distance from the promoter of the regulated 
gene (150). By forming a gene loop, Mediator bridges the vast distance 
between the enhancer and the promoter. For example, MED1 is required for 
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thyroid hormone receptor dependent juxtapositioning of enhancer and 
promoter elements at the Crabp1 gene (99). To stabilize gene loops, Mediator 
can be assisted by cohesin (151, 152). This four-subunit complex forms a 
ring around two DNA strands and holds them in place (153). An important 
function of cohesin is to hold the two sister chromatids together during 
metaphase. Mediator can bind to both cohesin and the cohesin-loading factor 
Nipbl (152). In mouse ES cells, Mediator and cohesion co-localize to both 
the promoter and the enhancer of the Nanog gene, and the resulting gene loop 
is dependent on both MED12 and the cohesin subunit SMC1a.  
Interestingly, Mediator seems to not only promote enhancer/promoter 
proximity but the complex also affects higher levels of chromatin 
organization. Mediator together with cohesin is required for the formation of 
dynamic, cell-type specific chromatin loops shorter than 100 kb (149). 
Independently of cohesin, Mediator also influences the formation of very 
short chromatin loops (600 – 1000 bp). Given the close connection between 
Mediator and cohesin, it is tempting to speculate that Mediator could utilize 
enhancer regions from a sister chromosome, or even an entirely different 
chromosome, to influence genes expression (145). 
An interesting new mechanism by which Mediator may regulate gene looping 
and gene activation has recently emerged. Long non-coding RNA species, 
called non-coding RNA-activating (ncRNA-a), associate with the CDK8 
module (154). The other end of the ncRNA-a can associate with an enhancer 
region several megabases from the regulated gene using sequence 
complementarity. The combination of ncRNA-a and Mediator can thus bring 
regulatory regions into proximity of a target gene, similar to the situation 
with transcriptional activators and gene looping. 
Chromatin remodeling 
Apart from being involved in recruitment of chromatin remodeling factors, 
Mediator can also directly modify histones. CDK8 can phosphorylate histone 
3 serine 10 (H3S10), which in turn stimulates the histone acetyltransferase 
GCN5L to acetylate lysine 14 (H3K14) on the same histone (155). Together, 
GCN5L and CDK8 interact with the transformation/transcription domain 
associated protein (TRRAP). This scaffold protein is known to cooperate 
with several chromatin-modifying complexes (156). CDK8 may promote 
transcriptional activity at genes by creating a permissive chromatin 
environment. In support of this notion, ncRNA-a binds to CDK8 and helps it 
to localize to a specific gene, which in turn leads to H3S10 phosphorylation 
and transcriptional activation of the gene (154). 
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Chromatin structure is not only important for gene activation, but also for 
suppression of gene transcription. For instance, MED12 has been found to 
suppress neuron specific genes in non-neuron cells (157). The protein 
connects the histone methyltransferase G9a with the RE1 silencing 
transcription factor (REST). G9a can then silence REST targeted genes 
through dimethylation of histone 3 lysine 9 (H3K9me2). Mutations in 
MED12 that inhibit binding of ncRNA-a to the Mediator complex also cause 
disassociation between Mediator and REST (154, 157). 
In S. pombe, the CDK8 module containing form of Mediator can associate 
with the chromatin-remodeling factor Hrp1 (homologue of Chd1 in S. 
Cerevisiae) (20622008). Together, Mediator and Hrp1 seem to have a 
positive impact on transcription of a subset of genes. In mammals, Mediator 
is also needed for CHD1 recruitment to genes (158). Here, CHD1 binds to 
trimethylated histone 3 lysine 4 (H3K4me3), a marker known to associate 
with active genes. Both Mediator and CHD1 can promote the formation of a 
PIC. 
Recent findings have demonstrated that Mediator also is crucial for 
controlling heterochromatin formation at different regions. As discussed in 
Paper I of this thesis, as well as the findings from other groups, Mediator is 
needed for transcriptional silencing of the telomere (159). The tail module of 
Mediator helps to control the boundary of silent chromatin at S. cerevisiae 
telomeres (160). The boundary is decided by the competitive interplay 
between the histone acetyltransferase Sas2 and the histone deacetylase Sir2, 
which both regulate the acetylation status of histone 4 lysine 16 (H4K16). 
Mediator binds to this region and influences Sir2 activity. In fact, 
deacetylation of H4K16 is essential for Mediator binding to the nucleosome 
(161). Mutations in MED5 of the tail module allow Sas2 to dominate and 
increase the spread of H4K16Ac with results in desilencing of the region 
(160). In support of these findings, genetic studies have shown that mutations 
in Mediator subunits can cause shortening of telomeres in S. cerevisiae (162).  
Also discussed in this thesis (Paper II) is the finding that Mediator helps 
regulate chromatin structure of the centromere (163-165). The 
transcriptionally silent heterochromatin of the pericentromeric region is 
needed for proper chromosome segregation during mitosis. Disruption of the 
S. pombe Mediator head module subunits Med18 and Med20 causes loss of 
heterochromatin and desilencing of the region. The levels of H3K9me, which 
is a characteristic feature of heterochromatin, drop significantly in these 
mutants. In addition, the centromere specific H3 variant CENP-A is lost from 
the core centromere when med20+ is deleted (164). 
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1.3.6 Mediator and human disease 
Mediator is involved in almost all Pol II dependent transcription in humans 
and it is therefore not surprising that mutations affecting this complex can 
cause a multitude of diseases. Among known diseases caused by impaired 
Mediator function are cardiovascular disease, cancer, as well as 
neurodevelopmental and behavioral disorders (166).  
Cardiovascular diseases 
MED13L, a paralogue of MED13, is highly expressed in heart and brain 
(167). Mutations in MED13L cause transposition of the great vessels (TGV) 
as well as congenital heart defects (167-169). Mutations in MED1 and 
MED30 cause lethal cardiomyopathy and mitochondrial defects (170, 171). 
Neurodevelopment disorders 
The hereditary motor and sensory neuropathy, Charcot-Marie-Tooth disease, 
has been associated with a point mutation in MED25 (172). The pathological 
pathway is still unknown, but it has been suggested that mutated MED25 
gene causes molecular lesions in Schwann cells that form the myelin sheaths 
surrounding the neuronal axons. 
Postnatal-onset microcephaly (POM) is a disorder characterized by 
decelerated head growth after birth, leading to a low cranial circumference, 
mental retardation, and seizures (173). Mutation affecting the essential 
Mediator subunit MED17 has been identified as the cause for this disease in a 
subset of patients (174). The corresponding point mutation in S. cerevisiae 
disrupts a crucial domain of the protein. 
MED12 has been connected to X-linked mental retardation (XLMR), or more 
specifically the FG and Lujan syndromes (154, 175). The MED12 protein 
helps to regulate Wnt, Notch and Sonic Hedgehog signaling, all of which are 
important in brain development pathways (176-178). MED12 is also 
important for epigenetic repression of neuronal gene expression in non-neural 
cells (157). In wild type cells, Mediator contribute to the establishment of 
repressive H3K9 dimethylation at specific genes and disease causing 
mutations in MED12 impair this function. Desilencing of these genes in turn 
causes pathological phenotypes. 
Behavioral disorders 
Schizophrenia is a chronic and severe mental disorder, characterized by 
delusions, hallucinations and paranoia. The disorder has hereditary 
tendencies, but the genetic background is complex, with influences from 
several different genes (179). A 12 bp insertion and a 15 bp deletion in the 
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MED12 gene have been identified as disease inducing mutations (180). These 
mutations are distinct from those responsible for the FG and Lujan 
syndromes (175, 181). The exact mechanism for MED12 mediated 
development of Schizophrenia is not known. However, there are data 
demonstrating that MED12 is crucial during development of dopaminergic 
neurons and deregulated dopamine signaling is a known risk factor in the 
development of schizophrenia (182, 183).  
Cancer 
Many studies have connected mutations in Mediator subunits to the 
development of cancer (184). The first reported example was the role of 
MED1 in breast cancer (185). The estrogen-receptor depends on MED1 to 
activate specific genes and mutations in MED1 cause a reduced response to 
estrogen (186).  Estrogen is a risk factor for development of breast cancer and 
MED1 is overexpressed in many tumors (187, 188). MED1 levels strongly 
correlate with the amount of human epidermal growth factor receptor 2 
(HER2) (189). Increased HER2 expression is an important step in the 
development of breast cancer and it causes resistance to hormonal treatment. 
MED1 has also been implicated in melanoma, prostate cancer, and lung 
cancer (190-192). 
MED28 has also been connected to the development of breast cancer, but the 
mechanism is distinct from that of MED1 (193). High expression of MED28 
causes increased proliferation, a common property of cancer.  MED28 levels 
are elevated in several different tumor types and can be used as a prognostic 
marker, with higher levels indicating poor prognosis (193, 194). 
Overexpression of CDK8 is common in several forms of colon cancers (195). 
CDK8 phosphorylates the transcription factor β–catenin, which in turn 
triggers increased expression of genes vital for colon cancer proliferation. In 
melanomas, CDK8 levels are also elevated. Expression of CDK8 in normal 
cells is repressed by the histone H2A isoform macroH2A (mH2A) (196). The 
levels of mH2A are reduced in malignant cells and as a consequence the 
CDK8 levels rise. Interestingly, MED1 expression is decreased in highly 
malignant melanoma cancers (192). This is an inverse situation compared to 
the high levels of MED1 expression observed in breast cancer. These 
contrasting observations demonstrate how complex and diverse the role of 
Mediator may be in different types of cancers. 
1.4 RNA Polymerase III 
While Pol II transcribes all the protein coding genes in the cell, Pol III 
transcribes many housekeeping non-coding RNAs. For instance, tRNA and 
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5S rRNA are transcribed from Pol III dependent genes (197). Pol III also 
transcribes snRNA (required for splicing) and snoRNA (guide RNA-
modifications) genes. Pol III is structurally and functionally distinct from Pol 
II, using different means for regulation of initiation and termination. 
1.4.1 Structure 
The core structure of Pol I, Pol II and Pol III is very similar. In yeast, twelve 
subunits of the different polymerases are homologues or identical to each 
other (198). Pol III also contains five additional subunits not found in the 
other polymerases. The pre-initiation complex of Pol III consists of the three 
factors: TFIIIA, TFIIIB, and TFIIIC (199). TFIIIB includes the TATA-
binding protein TBP and binds to upstream elements of Pol III promoters. 
TFIIIA and TFIIIC instead bind to intragenic promoter elements.  
The five distinct subunits of Pol III form two subcomplexes, 
Rpc31/Rpc34/Rpc82 and Rpc53/Rpc37, which are situated on either side of 
the Pol III ‘cleft’ (see 1.2.1) (200). The subcomplex Rpc31/Rpc34/Rpc82, 
which binds near the ’clamp’ of Pol III, is needed for promoter-dependent 
initiation and interactions with TFIIIB (201). The subcomplex also interacts 
with the Rpc17/Rpc25 subcomplex (homologues to Rpb4/Rpb7 in Pol II) that 
increases interactions with TFIIIB during Pol III initiation (202). 
The Rpc53/Rpc37 subcomplex associates with Rpc11 and is involved in 
termination and reinitiation of Pol III transcription (203). This subcomplex 
slows down the polymerase when it approaches the end of the gene to 
facilitate termination of transcription. The presence of Rpc11 in the 
subcomplex facilitates reinitiation of Pol III allowing for several rounds of 
transcription. Rpc53/Rpc37 mimics the role of TFIIF in Pol II as a stabilizer 
of the initiation complex (204).  
1.4.2 Gene structure and Pol III initiation 
The promoter elements of Pol III dependent genes differ from Pol II 
dependent genes. In fact, Pol III transcription factors primarily associate with 
promoter elements inside the gene body (197). There are four internal 
promoter elements: the A-, B-, C-boxes, and the intermediate element (IE). 
Based on primary promoter element compositions, three main types of 
promoters may be distinguished. Type 1 is used for expression of 5S rRNA 
and utilizes the A-box, C-box, and the IE. TFIIIA binds to the IE and C-box 
element and in turn recruits TFIIIC to the A-box resulting in subsequent 
recruitment of Pol III. Type 2 promoters that include the A-box and B-box 
regulate tRNA genes.  In this case only TFIIIC is required to bind the 
promoter elements. Interestingly, flanking the mating type region in S. pombe 
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are inverted repeat (IR) boundary elements, which contain multiple B-boxes 
(205). It has been shown that TFIIIC binds to these B-boxes and inhibits 
heterochromatin spread. In addition, TFIIIC has been implicated in 
organization of the genome by tethering these IR boundary elements to the 
nuclear periphery. 
In higher eukaryotes there is a third type of promoter that lacks both the A-
box and B-box. Instead, the promoter consists of a TATA-box and a proximal 
sequence element (PSE) upstream of the TSS (206). SNAPc (snRNA 
activating protein complex) recognizes the PSE and interacts with the TBP 
subunit of TFIIIB that recognizes the TATA-box, which in turn leads to Pol 
III recruitment (207). 
There is an increasing number of genes that are attributed to Pol III 
transcription (208). For instance, snoRNAs have previously been described 
as Pol II dependent. However in S. cerevisiae, transcription of the SNR52 
gene (snoRNA 52) has been shown to be Pol III dependent (209). The SNR52 
gene utilizes a type 2-like promoter upstream of the mature snoRNA52 
sequence (210). snoRNAs guide chemical modifications of other RNAs such 
A C TTTTIE
PSE
TFIIICTFIIIB
A B TTTT
TFIIIA
TATA
TFIIIBSNAPc
Type 1: e.g. rRNA 5S
Type 2: e.g. tRNA
Type 3: e.g. snRNA
TFIIIB TFIIIC
Figure 7. The three main promoter types of Pol III genes. 
The different sequence elements are discussed in the text. 
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as rRNA, tRNA, and snRNA (211). snoRNA have been identified as Pol III 
dependent also in other species such as Arabidopsis thaliana, C. elegans and 
D. melanogaster (212-214).  
1.4.3 Termination 
Termination of Pol III transcription is directed by a short poly(T) stretch on 
the non-template strand (197). Longer thymine stretches function as a 
stronger termination signal than shorter ones. However, some genes like 
SNR52 in S. cerevisiae include a stretch of 6 thymines and avoid premature 
termination by a termination-weakening signal surrounding this poly(T) 
sequence (215). The actual mechanism for Pol III termination is not yet 
known. However, transcription termination is directed by the newly 
synthesized transcript (216) and the proximity of Rpc53/Rpc37 to the exiting 
nascent RNA suggests that this subcomplex is involved in recognition of the 
poly(T) signal (poly(U) in RNA) (217). High elongation rates inhibit 
termination and Rpc53/Rpc37 has been suggested to function as a brake for 
the polymerase (218). Disruption of these subunits results in defective 
termination and read-through transcription. The poly(T) stretch causes 
pausing and backtracking of the polymerase. Pol III backtracks a short 
distance until it encounters a secondary structure, e.g. a hairpin, on the 
nascent RNA, which stimulates Pol III release. During this process, Rpc11 
mediates Pol III dependent 3ʹ′-cleavage of the nascent RNA (203). Rpc11 
includes an Rpb9-like domain that prevents read-through past the termination 
site, and a TFIIS-like domain needed for RNA 3ʹ′-cleavage (219). As 
mentioned above (see 1.4.1), the Rpc53/Rpc37/Rpc11 complex couples 
termination to reinitiation, enabling Pol III to rapidly switch from termination 
to a new round of transcription. 
1.5 Post-transcriptional Processing 
After a gene has been transcribed the resulting RNA needs further processing 
to become a mature transcript. Post-transcriptional modifications are diverse 
and include processes such as addition of a poly(A)-tail, splicing, and 
modification of specific nucleosides. 
1.5.1 Polyadenylation 
After termination, a stretch of adenines is added to the 3ʹ′-end of most 
mRNAs. The poly(A)-tail regulates the degradation rate of the transcript and 
assists in the export of mRNA from the nucleus (220). The process of 
polyadenylation is tightly coupled to transcription termination (221). In 
eukaryotes, adenines are added by the Poly(A) polymerase (PAP), which is 
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tethered to the nascent RNA by CPSF during the transcription termination 
event (222). PAP is further anchored to the nascent RNA by the poly(A)-
binding protein nuclear 1 (PABPN1) that binds to the poly(A)-tail after the 
addition of 11 adenines. The formation of the PAP-PAPBN1-CPSF complex 
switches PAP from a distributive to a processive mode, leading to the 
formation of longer poly(A) tails. The average poly(A) length is 250 
nucleotides in humans and between 40 and 70 nucleotides in yeast (223). 
How poly(A)-length is regulated is still unclear, but current models suggest 
that during poly(A) elongation PABPN1 forms a globular complex with the 
poly(A)-tail. The complex cannot accommodate further nucleotides when the 
poly(A) reaches 250 nucleotides. At this point CPSF is forced to dissociate 
from PAP, which causes reduced processivity by PAP. Although the 
mechanism is supposed to be very similar in yeast and human cells, S. 
cerevisiae does not contain a PABPN1 orthologue. Instead the PAP 
homologue Pap1 utilizes Nab2 (nuclear polyadenylated RNA binding 2) to 
regulate the poly(A) length and nuclear export (224).  
Once the poly(A)-tail has been produced, PABPN1 transports the nascent 
RNA to the nuclear pore complexes (NPC), which export the mRNA 
molecule over the nuclear membrane (223). After transport to the cytoplasm, 
the poly(A)-tail is instead bound by PABPC1 in order to protect the mRNA. 
The mature mRNA also contains a 5ʹ′-cap structure that associates with 
eukaryotic translation initiation factors (eIFs) (225). The eIFs and PABP 
interact with each other to form a closed mRNA loop, which both protects the 
mRNA and enables it to initiate translation (226). Many processes in the 
cytoplasm modify poly(A) length. For instance, PUF-family proteins 
recognize a 3ʹ′ untranslated region (UTR) on the transcript and recruit 
deadenylases causing shortening of the poly(A)-tail (227). Similarly, ARE-
binding proteins bind to the UTR ARE (AU-rich element) and recruit 
deadenylases, such as the poly(A) ribonuclease (PARN) (228). The poly(A)-
tail is not only shortened but can also be elongated in the cytoplasm (229). 
The cytoplasmic polyadenylation element binding protein (CPEB) binds to 
the poly(A)-tail and can recruit both a deadenylase and the cytoplasmic PAP 
GLD2 simultaneously. Although the deadenylase has higher efficiency, 
resulting in net shortening of the poly(A)-tail, phosphorylation of CPEB 
causes dissociation of the deadenylase, enabling GLD2 to elongate the 
poly(A)-tail. When the poly(A)-tail has been substantially deadenylated 
PABP detaches from the poly(A)-tail causing dissociation of the closed loop 
(226). As a consequence the ability of the mRNA to be translated is reduced 
and it becomes targeted for RNA degradation. 
Apart from the canonical nuclear PAP there are several non-canonical 
poly(A) polymerases (ncPAP) as for example the aforementioned GLD2 
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(230). The S. pombe ncPAP Cid1 adds a short uridylated tail on 
polyadenylated mRNAs. Uridylation in turn stimulates decapping of the 5ʹ′-
cap, thus inducing RNA-decay (see 1.6.2) (231).  
Cid14 is another ncPAP in S. pombe (Trf4/Trf5 in S. cerevisiae) and this 
enzyme is a part of the TRAMP complex (the trimeric Trf4/Trf5-Air1/Air2-
Mtr4 polyadenylation complex) (232). TRAMP targets a large variety of 
transcripts for degradation e.g. aberrant mRNA, pre-rRNA, snRNA, 
snoRNA, defective tRNA, and spliced introns (233). In addition, TRAMP is 
also involved in gene silencing and heterochromatin formation at the 
centromere (234). Cid14 differs from canonical PAPs in that it has a 
preference for incorporating purines and not only adenine, and can thus add 
both adenine and guanosines into the poly(A)-tail (235). The length of the 
poly(A) tail is regulated by the TRAMP helicase Mtr4p (236).  The 
nucleotide composition together with the length of the poly(A)-tail 
distinguishes these transcripts from those with a canonical poly(A)-tail (235, 
236). This could explain why TRAMP polyadenylated transcripts are targeted 
for rapid degradation while a normal poly(A)-tail protects the associated 
transcript.  
1.5.2 Splicing 
The human genome have about 20 0000 - 25 000 protein-coding genes (237). 
However, there are many more functionally distinct proteins in the cell. The 
gene body consists of protein-coding sequences (exons) spaced by non-
protein-coding sequences (introns) (12). After transcription, the pre-mRNA 
includes both intron and exon sequences. The process of splicing removes the 
introns and may also exclude some exons from the mature mRNA. By 
combining different exons a large variety of protein products can be 
produced, a process termed alternative splicing (238). These protein variants 
can for instance enable tissue specific protein functions.  
The spliceosome is a megadalton RNA-protein complex, which may vary in 
composition, thus enabling the complex to regulate a large variety of targets 
(12). The classical U2-spliceosome contains the snRNAs U1, U2, U4, U5 and 
U6, which are each associated with seven Sm proteins (B/Bʹ′, D1, D2, D3, E, 
F, G), except for U4/U6 that are in the same snRNP. There are three active 
regions in an intron, the 5ʹ′- splice site (ss), the 3ʹ′-ss and the branch site (BS). 
Initially, the U1 snRNP is translocated to the 5ʹ′-ss and non-snRNP factors are 
attached to BS. Subsequently, U2 snRNP also binds to the BS, which forms 
the pre-spliceosome (A complex). In the next step, the U5 snRNP/U4/U6 
snRNP complex is recruited to the splice site (the pre-catalytic B complex). 
Activation occurs when U1 and U4 snRNP are dissociated from the 
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assembled spliceosome. Destabilization of the U2 snRNP component enables 
the spliceosome to cleave the 5ʹ′-ss (239). The 5ʹ′-end of the intron is then 
bound to the BS (C complex) causing consecutive cleavage at the 3ʹ′-ss (12). 
Finally the two processed exon ends are ligated together.  
Not only mRNA contains introns. A subset of human (6%) and S. cerevisiae 
(21%) tRNA genes also have an intron (240). In yeast, the introns are 
removed by the tRNA-splicing endonuclease (TSEN) that cleaves both the 5ʹ′-
ss and 3ʹ′-ss resulting in an excised intron and two tRNA-exon molecules, 
which are fused together by tRNA ligase to form an intron-free pre-tRNA 
(241). 
1.5.3 tRNA processing 
The function of tRNA, rRNA, snRNA, and snoRNA is dependent on their 
secondary structures. The tRNA gene transcripts do not only need to be 
folded correctly but they must also be processed at the 3ʹ′- and 5ʹ′-ends as well 
as spliced and modified at certain nucleosides. tRNA genes are transcribed in 
the nucleolus, forming a pre-tRNA transcript (242). The pre-tRNA contains a 
5ʹ′-leader and a 3ʹ′-trailer sequence that need to be removed. Usually, the 
endonuclease RNase P cleaves the 5ʹ′-leader before the 3ʹ′-trailer is removed 
(243). In these cases, the pre-tRNA is then exported to the nucleoplasm 
where a La protein (Lhp1 in S. cerevisiae) binds to the oligo(U) stretch at the 
3ʹ′-end (242). The RNase Z endonuclease (Trz1 in S. cerevisiae) then cleaves 
and removes the 3ʹ′-trailer (244). However, Lhp1 competes with the 3ʹ′-5ʹ′ 
exonuclease Rex1 for binding to the oligo(U) stretch (245). While Lhp1 
prefers a length of more than three uridines, Rex1 predominantly binds to 
sequences containing only one or two uridines (244). For the pre-tRNAs that 
are processed by Rex1, the digestion of the 3ʹ′-trailer precedes the cleavage of 
the 5ʹ′-leader by RNase P.  
Not only Lhp1 and Rex1 compete for access to the 3′-trailer. The TRAMP 
complex (see 1.5.1) can also bind to a single stranded 3′-trailer with the 
length of at least three nucleotides (244). As a result the transcript is 
polyadenylated and thus marked for degradation by the exosome (see 1.6.1). 
Pre-tRNAs that are associated with Lhp1 are protected from the activity of 
TRAMP until RNase Z has processed the 3′-end, leaving only a single 
nucleotide overhang, which precludes TRAMP binding. In contrast, 3′-
trimming by Rex1 occasionally leads to the formation of aberrant transcripts 
that are targeted by TRAMP to mark them for degradation (245). Defective
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A) >3 oligo(U) B) 1-2 oligo(U) C) Aberrant transcript
Lhp1
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Figure 8. Processing of pre-tRNA 
Maturation of pre-tRNA can take two pathways depending on the length of the oligo(U) 
termination signal. A) pre-tRNAs with 1-2 Us are recognized by Rex1 that cleaves the 3ʹ′-
trailer. The 5ʹ′- leader is then removed by RNase P. B) Transcripts with more then 3 Us are 
bound by Lhp1. RNase P then removes the 5ʹ′- leader followed by RNase Z mediated 
digestion of the 3ʹ′-trailer. C) Aberrant pre-tRNA transcripts in the Rex1 pathway are 
polyadenylated by TRAMP complex and consequativly degrade by the exosome subunit 
Rrp6. D) After trimming of 3ʹ′- and 5ʹ′-end intron containing pre-tRNA are spliced to produce 
mature tRNA. 
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tRNAs are then degraded by the exosome, while mature tRNA turnover is 
controlled by Xrn1 of the decapping machinery (242, 244).  
A sequence of CCA at the 3ʹ′-end of the tRNA is needed for loading of the 
amino acid (246). After removal of the 3ʹ′-trailer, the yeast tRNA 
nucleotidyltransferase Cca1 adds CCA to the 3ʹ′-end.  
The location of tRNA introns is always one base downstream from the 
anticodon site (242) and the splicing process is needed for certain nucleoside 
modifications at this position (247).  
In yeast, the tRNA splicing endonuclease removes the intron leaving a 2ʹ′-3ʹ′ 
cyclic phosphate group on the 3ʹ′-end of the first exon (242). The ligase Trl1 
phosphorylates the 5ʹ′-end of the second exon, and thus enables ligation. 
Splicing of tRNA occurs in the nucleus in humans, but in yeast it instead 
occurs on the outer surface of mitochondria (248, 249). 
Nucleosides are heavily modified in tRNA and over 85 different 
modifications have been identified (250). There is a large number of enzymes 
involved in tRNA modification processes and many of them have been 
characterized. Modifications in the vicinity of the anticodon are needed for 
translation and cellular growth (251, 252) while the stability and folding of 
tRNA is usually dependent on modifications in the tRNA body (251-254). 
Finally, certain modifications help to identify a specific tRNA ((255, 256)). 
1.6 RNA degradation 
The balance between mRNA production and degradation decides the steady-
state levels of specific transcripts. The degradation pathways are also used for 
RNA quality control by rapid degradation of aberrant RNA species 
occasionally produced by the different RNA polymerases. As discussed 
above (see 1.5.1), poly(A)-tails influence RNA stability (257). Shortening of 
the poly(A)-tail triggers mRNA degradation by the 3ʹ′-5ʹ′ exoribonuclease 
exosome complex or the 5ʹ′-3ʹ′ exoribonuclease decapping complex (258, 
259). Polyadenylation of aberrant transcripts by the TRAMP complex has the 
opposite effect and leads to rapid degradation by the exosome (260). 
Transcripts are also protected from degradation by RNA-binding proteins in 
RNP complexes. Defective mRNAs have reduced affinity for these proteins, 
leading to increased access for degrading enzymes (261). A stable secondary 
structure in the RNA can also interfere with the degradation process (262).  
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1.6.1 The exosome 
The 3ʹ′-5ʹ′ RNA degradation pathways are functionally conserved from 
bacteria to humans (258). There are three major 3′-5′ exoribonucleases in 
eukaryotes: the main catalytic subunit of the exosome Rrp44 (Dis3 in S. 
pombe), the nucleus specific exosome subunit Rrp6, and the mitochondrial 
PNPase. (263). In the cytoplasm, the exosome complex contains nine core 
subunits (Exo9) and Rrp44 (Exo10). In addition to the Exo10 subunits, the 
exosome present in the nucleus also contains Rrp6, thus forming Exo11. A 
third type of exosome has been hypothesized in the nucleolus, which only 
includes Exo9 and Rrp6 but not Rrp44 (264). The Exo9 core regulates the 
accessibility of RNA to Rrp44 and Rrp6 and modulates the activity of these 
enzymatic subunits (265). 
The eukaryotic core exosome consists of nine unique subunits (263). Three 
subunit pairs, Rrp41-Rrp45, Rrp46-Rrp43 and Mtr3-Rrp42 form a hexamer 
ring just large enough to enable single stranded RNA to enter the central 
channel (266). Capping the hexamer ring are the three subunits Csl4, Rrp4, 
and Rrp40. At the bottom of the channel is Rrp44 that digests the entering 
single stranded RNA. The second enzymatic subunit, Rrp6, is instead located 
at the top of the complex.  
In addition to its exoribonuclease activity, Rrp44 is also an endoribonuclease 
(267). Whereas the exoribonuclease domain of Rrp44 degrades linear 5ʹ′-
phosphorylated ssRNA, the endonuclease domain processes other RNA 
species including circular RNA (267). The targeted RNA needs an at least 9 
nucleotide long single stranded overhang to be directly processed by the 
exoribonuclease domain of Rrp44 (268). However, Rrp44 can unwind 
double-stranded structures if a single-stranded overhang of at least 4-8 
nucleotides is exposed. Interestingly, the unwinding activity of Rrp44 does 
not seem to be ATP driven like conventional helicases. Instead, the complex 
retains the force produced by four consecutive nucleotide cleavages of the 
single stranded overhang. The narrow exosome channel causes steric 
occlusion of double stranded RNA structures until the accumulated force 
separates the two strands in a burst (262). Cooperation between the 
endoribonuclease and exoribonuclease domains enables a second mechanism 
for Rrp44 to degrade structured RNAs. The endoribonuclease cleaves the 
RNA at the loop of a hairpin structure, which facilitates separation of the two 
strands and further processing by the exoribonuclease (269).  
The nucleus specific exosome subunit Rrp6 functions in the mRNA 
surveillance pathways (270). Rrp6 has also been implicated in processing of 
many small, structured RNAs (271). As discussed in Paper IV of this thesis, 
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these targets include tRNA, rRNA, snoRNA, and snRNA. Rrp6 seems 
primarily to be involved in degradation and quality control of these 
transcripts. For instance, Rrp6 degrades pre-tRNAs that fail the quality 
control (244). Yeast cells lacking Rrp6 are viable but display accumulation of 
polyadenylated transcripts in the nucleolus, which is the location of tRNA 
genes (272, 273). Evidence has suggested that Rrp6 and Rrp44 can cooperate 
in the degradation process of at least some small, structured RNAs (271). 
There are also reports of Rrp6 functioning independently of the core exosome 
(274).  
Co-factors, such as the TRAMP (see 1.5.1) and SKI (super killer), help the 
exosome to achieve high target specificity (260, 275). Other examples are 
Rrp47, a cofactor that interacts with Rrp6 and helps it in the maturation 
process of 5.8S rRNA (276), and Mpp6, a RNA binding protein that is 
needed for surveillance of pre-rRNA, pre-tRNA, and cryptic ncRNA (277). 
Sequence elements in transcripts can also regulate exosome activity. The AU-
rich element (ARE) is found in highly unstable transcripts such as cytokines 
and other inflammatory transcripts (228, 278). ARE is located in untranslated 
regions of the transcript and is bound by AUBP (the ARE-binding protein). 
The exosome can interact with AUBPs in order to rapidly degrade transcripts 
(278). For instance, the RNA helicase RHAU recognizes specific AUBPs and 
in turn recruits the poly(A)-specific ribonuclease (PARN) and the exosome, 
resulting in RNA decay (279). 
The nuclear exosome associates with the non-canonical polyadenylation 
complex TRAMP (see 1.5.1) to promote exosome dependent degradation of 
aberrant transcripts (260). However, both the exosome and TRAMP is also 
involved in normal 3ʹ′-processing. For example, Nrd1 recruits the exosome 
and TRAMP to the Nrd1-Nab3-Sen1 binding site of snoRNA genes where it 
trims the 3ʹ′-end of nascent transcripts (280). The transcript needs to be 
associated with a protective RNA-binding protein in order to avoid that the 
exosome digests the entire RNA. Nrd1 also connects Pol II transcribed RNA 
with TRAMP and the exosome (281).  
In the cytoplasm, the exosome interacts with the SKI complex (super killer) 
(275). Together they are involved in several different RNA decay pathways. 
For instance, RNA that has been cleaved by the RNA interference (RNAi) 
machinery (see 1.6.3) is completely degraded by the exosome (282). 
Furthermore, three different pathways are used to degrade defective mRNA. 
First, the nonsense mediated decay (NMD) pathway removes mRNAs with 
premature termination signals (283). Secondly, the non-stop decay (NSD) 
pathway processes transcripts lacking a termination sequence (284). Finally, 
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transcripts that are stalled in the ribosome are degraded by the no-go decay 
(NGD) pathway (285).  
1.6.2 The Decapping complex 
The second major RNA decay pathway operates through the decapping 
complex that removes the 5ʹ′-cap of the transcript and enables 5ʹ′-3ʹ′ 
exoribonuclease RNA decay (286). Upon exiting active translation, the 
mRNA can be deadenylated, which results in recruitment of the decapping 
complex to the transcript. The decapping complex subunits Dcp1 and Dcp2 
along with additional factors and the mRNA, form the decapping P-body 
unit. In yeast, the decapping complex subunit Dcp2, with the support of 
Dcp1, removes the RNA 5ʹ′-cap, a protective cap formed by a N7 methylated 
guanosine triphosphate (m7Gppp) linked to the 5ʹ′-end of mature mRNA via a 
5ʹ′-5ʹ′ triphosphate bridge (287). This enables the 5ʹ′-3ʹ′ exoribonuclease Xrn1 
to digest the targeted RNA (288). Deadenylation of the mRNA is needed 
prior to decapping since the poly(A)-binding protein Pab1 inhibits the 
decapping process (259). The cap-binding complex eIF4E associates with the 
5ʹ′-cap of RNA in yeast, and inhibits the activity of the decapping complex 
(289). The RNA-binding proteins Edc1 and Edc2 can however alleviate the 
inhibitory effect of eIF4E, allowing the decapping complex to remove the 5ʹ′-
cap.  
1.6.3 RNAi 
RNA interference (RNAi) can influence gene expression at many different 
levels, including transcription, mRNA turnover, translation, and regulation of 
chromatin structure (290). RNAi utilizes several species of small RNAs to 
exert these functions. The small interfering RNA (siRNA) molecules are 
completely complementary to a specific RNA target (291). Hybridization 
between the target and the siRNA leads to degradation of the transcript by the 
RNAi machinery. Another group of regulatory RNA molecules is micro 
RNA (miRNA), which are partially complementary to the target RNA (292). 
The rest of the miRNA forms a hairpin structure that for instance can 
interfere with translation. Yet another type of RNA with regulatory potential 
is PIWI interacting RNA (piRNA), which silences transcription of 
transposons genes (293). 
The biogenic pathways of the different small RNA species differ from each 
other. miRNAs are originally transcribed as long primary miRNAs (pri-
miRNA) (294), which are processed by the microprocessing complex into 70 
nt long stem-loop structures called pre-miRNAs (295). These precursors are 
then transported into the cytoplasm where the hairpin loops are removed by 
the endoribonuclease Dicer, thus creating 21 bp long complementary double 
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strand RNAs (296). A helicase separates the two strands, allowing one of 
them, designated the guiding strand, to associate with the complementary 
target. The 3ʹ′ region of the miRNA is not complementary with the targeted 
RNA and instead forms a hairpin that interferes with translation of the target 
mRNA.  
Double stranded pre-siRNA is produced in four different fashions: 
convergent transcription, complementary sense and antisense transcription, 
structured loci, or RNA dependent RNA complex (RDRC) produced dsRNA 
from a single stranded transcript (290). The dsRNA is then digested by Dicer 
to produce 21 bp long fragments. One strand is discarded allowing the other 
strand to bind to its completely complementary target. The siRNA promotes 
cleavage of the target RNA with the help of the RNA-induced silencing 
complex (RISC) (297). 
In D. melanogaster, pre-piRNA is transcribed from gene clusters that encode 
antisense sequences complementary to transposon RNA (293). The pre-
piRNA is then exported to the cytoplasm where it is cleaved into piRNA 
fragments by an endonuclease, followed by loading onto either Piwi protein 
or Aubergine (Aub). The piRNA is further trimmed and modified, and finally 
binds to the targeted transposon RNA, which is cleaved by Aub.  
Argonaute proteins bind all the different classes of RNAi associated small 
RNA molecules and help to guide them to the correct target (298). In this 
process, the double stranded small RNA first binds to the Argonaute protein, 
after which one of the strands (the passenger strand) is discarded while the 
guiding strand remains (298). The 5ʹ′-end of the guiding strand has low 
affinity to the 3ʹ′-end of the passenger strand and recognition of this instability 
allows the Argonaute protein to decide which strand to keep (299). The 
guiding strand of either the miRNA or the siRNA binds to Argonaute 
proteins in RISC and guides the complex to the targeted mRNA (300). Some 
Argonaute proteins include an endonuclease ‘slicer’ domain that can cleave 
complementary target RNA (301). In humans there are four Argonaute 
proteins, but only AGO2 has a ‘slicer’ domain (302). The Argonaute proteins 
promote post-transcriptional gene silencing (PTGS) also via other processes, 
for instance by influencing the deadenylation process, decapping activity, 
inhibition of translation and association with the degrading P-body (303). 
The Argonaute proteins include a PAZ (Piwi Argonaute Zwille) domain that 
recognizes and binds the ssRNA or dsRNA with a 2 nucleotide 3ʹ′-overhang, 
while the MID domain recognizes the phosphorylated 5ʹ′-end of the small 
RNA (298, 304). In fission yeast Ago1 is the only Argonaute protein and the 
protein includes an endonuclease ‘slicer’ domain (305). 
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The Dicer family of class 3 RNase III enzymes controls the production of 
small RNA from double stranded precursor RNA (306). The pre-RNA binds 
to the Dicer double stranded RNA binding domain (dsRBD). The PAZ 
domain of Dicer can then decide the correct length of the small RNA to be 
produced, usually between 21 and 28 nucleotides (307). Dicer cleaves the 
associated double stranded RNA by hydrolysis of phosphodiester bonds 
(308).  The enzyme can process a long dsRNA using its helicase domain and 
ATP to move along the substrate and digest the entire length (309). Dicer can 
also target ssRNA loops for small RNA production as in the case of pre-
miRNA processing (310). 
RNA dependent RNA polymerase (RDRP) is a vital component of the RNAi 
machinery (311). It converts ssRNA into dsRNA, which is then processed by 
Dicer to produce siRNA. This mechanism is for instance used in the defense 
against viral RNA species and in the regulation of chromatin structure at 
centromeres. In plants, Dicer digests viral dsRNA into siRNA that in turn 
guides RDRP to other viral ssRNAs to in order to convert them to dsRNA 
(312). Dicer can then digest and neutralize the double stranded viral RNA, 
and as a byproduct produce more antiviral siRNA. There is no RDRP 
counterpart yet identified in humans. However, Pol II has been reported to 
have RDRP activity (313).  
In fission yeast, the RNA induced transcriptional silencing (RITS) complex is 
guided to centromeric transcripts by siRNA associated with Ago1 (314). In 
turn, RITS recruits the RDRP complex to the centromere that converts the 
centromeric transcripts into dsRNA. This enables Dicer to produce more 
siRNA leading to further recruitment of RITS to the centromere. This process 
leads to heterochromatin formation at the centromere, a major topic in Paper 
II of this thesis. 
1.7 Chromatin 
Packaging of the genetic material into chromatin helps to regulate both 
genomic organization and gene expression.  
1.7.1 Heterochromatin, Euchromatin and the 
Nucleosome 
The nucleosome protein core consists of two copies each of the four subunits 
H2A, H2B, H3 and H4 (315). DNA (147 bp) tightly wraps around the 
histones with the aid of many DNA-protein interactions (316). One histone 
H1 subunit (linker histone) binds to DNA on the outside of the nucleosome, 
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leading to the formation of the chromatosome (317). The spacing between 
nucleosomes differs depending on the genomic location (318).  
Protruding from the nucleosome are the histone tails containing residues 
commonly targeted by histone modifiers to control epigenetic regulation, 
chromatin structure, and gene expression (14). Examples of modifications to 
these residues are methylation, acetylation, and phosphorylation. For 
instance, active genes are commonly marked by histone modifications such 
as H3 serine 4 trimethylation (H3K4me3) and acetylation of H3 serine 9 
(H3K9ac) (319). Nucleosome function can also be regulated by the exchange 
of canonical histones to specific histone variants, such as CENP-A 
(centromeric H3 variant) and H2A.Z (320, 321).  
Transcriptionally repressed and nucleosome dense heterochromatin regions 
are marked by hypoacetylation and methylation of H3 serine 9 (H3K9me) 
(322). A precise boundary between heterochromatin and euchromatin is vital 
for avoiding unwanted activation or repression of bordering genes. 
1.7.2 Centromere 
The centromere is the genomic region where the kinetochore assembles 
during mitosis. Microtubules attach to the kinetochore and the centrosome, 
enabling separation of the chromosomes during cell division (323). A 
dysfunctional centromere leads to chromosome instability and loss of genetic 
information during mitosis. The size of the centromere varies between 125 bp 
in S. cerevisiae, 40-100 kb in S. pombe, and several megabases in humans 
(324).  
The core centromere is distinguished by the H3 variant CENP-A (Centromere 
protein A) (325). Overexpression of CENP-A in D. melanogaster causes 
incorporation of CENP-A in non-centromeric locations resulting in assembly 
of a functional ectopic kinetochore (326). Centromeric core chromatin is 
distinct from both euchromatin and heterochromatin (327). Interspersed 
between CENP-A containing nucleosomes are nucleosomes with canonical 
H3 dimethylated at the serine 4 position (328). CENP-A is removed during 
replication and later reintroduced to enable kinetochore assembly (329). 
Newly synthesized CENP-A is incorporated into centromeric nucleosomes 
with the help of HJURP (Holliday junction recognizing protein) and the 
Mis18 complex.  
CENP-A is the key kinetochore-assembly factor. There are over 80 proteins 
that constitute the kinetochore (330). Kinetochore is divided into an outer 
plate that connects to the microtubule, and an inner plate containing CENP-A 
and several other CENP proteins, forming a constitutive centromere 
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associated-network (CCAN). While CCAN is present during most of the cell 
cycle, the other factors of the kinetochore are assembled at different stages 
between late G2 and the end of mitosis. The general structure of the 
kinetochore is conserved in eukaryotes (330). However, the number of 
kinetochores occupying each centromere differs between species. For 
instance, S. cerevisiae have point centromeres covered by a single 
kinetochore while the regional centromeres of S. pombe and humans are 
bound by many kinetochores (331).  
The function of the core centromere (cnt) in S. pombe is dependent on the 
surrounding chromatin structure. The flanking pericentromeric region is 
covered by heterochromatin and is primarily transcriptionally silent (332). 
Bordering the cnt on both sides is the inner most repeat (imr), proceeded by 
the outer repeat region (otr), which is further subdivided into the dg and dh 
elements. The sequence of the repeat region on one side is almost perfectly 
mirrored on the other side of cnt (333). In S. pombe, there is little size and 
sequence variation between the cnt regions of the individual chromosomes 
(332). The size of imr does not differ between the chromosomes either, but 
the sequence partially differs, enabling identification of the chromosome. 
Even though the sequence of otr is conserved between chromosomes, the 
copy number and orientation of the dg and dh elements differ. 
Although there are no protein-coding genes in the centromere, there are 
ncRNA and tRNA genes in otr and imr (334). Transcription of 
pericentromeric genes is restricted to a short window associated with the 
replication events of S-phase (335). Dicer (Dcr1), the ribonuclease of the 
RNAi machinery, rapidly processes centromeric ncRNA transcripts into 
siRNA (336). The siRNAs are then loaded onto Ago1 of the RITS complex 
(RNA-induced transcriptional silencing), and guide RITS to actively 
transcribed centromeric genes (Figure 9) (314). Association of RITS to the 
nascent RNA recruits RDRC, including the RNA-directed RNA polymerase 
(Rdp1) that converts the transcript into double stranded RNA. The double-
stranded RNA is then processed by Dicer to produce more siRNA, creating a 
positive feedback loop.  
RITS association with nascent transcripts also recruits the Clr4 
methyltransferase complex (ClrC) that methylates H3K9, a marker of 
heterochromatin (337). The RITS subunit Chp1 binds to H3K9me and thus 
further stabilizes RITS’s association with the centromere. De novo 
establishment of heterochromatin is initiated by methylation of H3K9 at two 
nucleation sites in dg associated with ncRNA genes (338). In order for Clr4 
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Figure 9. RNAi-dependent heterochromatin formation at the pericentromeres 
A) Pol II transcribes ncRNA in the pericentromeric region. B) RDRC copies the ncRNA 
and creates dsRNA that is used as substrate for Dcr1 to produce siRNA. C) The siRNA 
associates with the Ago1 subunit in the RITS complex. The siRNA helps to recruit RITS 
to the nascent ncRNA. RITS stimulates recruitment of RDRC for further production of 
siRNA. D) RITS recruits Clr4, which methylates H3K9 in the pericentromeric region. E) 
Swi6 binds to H3K9me. F) Swi6 recruits Clr3, which together with Sir2 deacetylates 
H3K9. G and H) Clr3, Clr4, and Swi6 cooperate to stimulate spread of H3K9me and 
heterochromatin. H) Pol II activity is repressed by heterochromatin formation. Reduced 
transcription limits the nucleosome turn over and further facilitates spreading of silent 
chromatin. 
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to methylate H3K9, it must be deacetylated by Sir2 or Clr3. The H3K9me 
binding chromodomain proteins Swi6 and Chp2 recruit these histone 
deacetylases (HDACs) to the centromere. As previously mentioned (see 
1.7.1), H3K9ac is associated with active promoters and enables Pol II 
transcription (339). The activity of Pol II can counteract methylation of 
H3K9 by Clr4. Thus, deacetylation of H3K9 at the centromeric promoter 
inhibits Pol II activity and leads to the stable establishment of H3K9me 
(338). Once stable H3K9me is established at the nucleation sites, the 
heterochromatin can start to spread outwards.  
The tRNA genes located inside imr and flanking the outer perimeter of the 
pericentromere, keep the heterochromatin from spreading into the core 
centromere and the flanking euchromatin (332, 340). The Pol III general 
transcription factor TFIIIC contributes to the establishment of chromatin 
boundaries in fission yeast (205). However, at imr tDNA, TFIIIC alone does 
not prevent the spread of heterochromatin (340). Instead, recruitment of the 
entire Pol III machinery is needed to stop heterochromatin spreading into cnt.  
1.7.3 Telomere 
In eukaryotes the chromosomes are linear with vulnerable ends, which are 
protected by telomeres. The DNA repair machinery can interpret these ends 
as double stranded DNA breaks (341). During replication, the DNA 
polymerase cannot replicate from the very end of the chromosome, due to the 
requirement of a RNA primer (342).  Instead a short fraction of the telomere 
is lost. This results in shortening of the telomeres at each cell division, the so-
called end-replication problem. If the cells did not compensate for this 
problem there would eventually be a loss of genetic information and finally 
cell death. To circumvent the end-replication problem the reverse 
transcriptase telomerase increase the length of the chromosome ends. While 
shortening of the telomeres leads to reduced life span, overexpression of 
telomerase can establish immortalized cell lines (343).  
The telomere consists of a cap followed by the telomere-associated sequences 
(TAS) (344).  In vertebrates the cap is composed of TTAGGG repeats ending 
in a single stranded 3ʹ′-overhang (345). In yeast this region is nucleosome free 
but covered with other DNA binding complexes. In contrast, the vertebrate 
cap does contain nucleosomes. The chromatin structure of the telomere 
resembles heterochromatin and is characterized by silencing and 
heterochromatin specific histone modifications. In S. cerevisiae, the 
subtelomere is divided into the two TASs, X and Yʹ′ (346). The X region is 
found in all chromosomes and has a low nucleosome density. In contrast, the 
Yʹ′ region has high nucleosome density and is only present in some 
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chromosomes with varying copy number. Interestingly, although Yʹ′ has a 
higher nucleosome density it has intermittent transcriptional activity, while X 
is always silent and is associated with the silent information regulator (Sir) 
proteins.   
After replication, a single stranded 3ʹ′-overhang is added to the telomere end 
(347).  In humans, the POT1 protein binds the overhang, which is then folded 
into an upstream telomere sequence, forming a T-loop (348). The invading 
overhang separates the two strands of the upstream sequence and then binds 
to it, forming a D-loop structure. The TRF proteins of the shelterin complex 
facilitate T-loop formation by bending the telomeric DNA (349). In S. pombe 
there are homologues for the shelterin complex, but in S. cerevisiae there are 
no orthologues to the TRF proteins (350). In human and S. pombe the 
repressor-activator protein (RAP1), binds to the telomere through association 
with TRF2. Since S. cerevisiae lacks TRF proteins Rap1 instead binds to 
telomere DNA directly. Several shelterin complexes can bind to long 
telomeres, while short telomeres contain fewer complexes (351). High 
abundance of shelterin at the telomere inhibits telomerase by POT1 binding 
to the single stranded overhang. This system enables a mechanism for 
regulation of telomere length.  
In S. cerevisiae, Rap1 can recruit Sir4 into the subtelomeric region, which in 
turn leads to recruitment of Sir2 and Sir3 (352). Binding of the Sir proteins 
causes silencing of the subtelomeric region (353). While Sir3 and Sir4 are 
structural proteins Sir2 is a HDAC that deacetylates H4K16. The 
deacetylation of H4K16 enables Sir3 and Sir4 to bind to H3 and H4 tails 
(354, 355). This results in a positive feedback loop that spreads the Sir-
proteins over subtelomeric region. The deacetylase activity of Sir2 is 
counteracted by the histone acetyltransferase (HAT) Sas2 (356). 
Hyperacetylation caused by Sas2 inhibits Sir3 and Sir4 binding and creates a 
subtelomeric boundary. Mediator is involved in regulating the balance 
between Sir2 and Sas2, which is the main focus of Paper I. 
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2 AIMS OF THIS THESIS 
The Mediator complex was initially believed to only function as a bridge 
between gene specific transcription factors and the transcription machinery at 
the promoter. Over time, many other functions have been attributed to the 
complex. Among these is the ability of the complex to regulate chromatin 
structure by promoting histone modifications, both directly and indirectly 
(155, 157, 357). In this thesis, we set out to investigate if Mediator is 
involved in regulation of heterochromatin structure. 
We first decided to study how Mediator affects heterochromatin formation at 
telomeres (Paper I). To this end we opted to use S. cerevisiae, since previous 
work in this model organism had identified Mediator mutants that caused 
telomere length alternations and influenced telomere silencing (358, 359). 
We also investigated the effect of Mediator on heterochromatin formation at 
centromeres. For this work, we used S. pombe, which, compared to S. 
cerevisiae, has a centromere organization more similar to that found in 
mammalian cells (360). Tight regulation of centromere transcription is 
crucial for maintaining a correct chromatin structure at the centromere and as 
a regulator of Pol II, Mediator was a prime candidate for regulation of 
centromeric transcription. In addition, Mediator had previously been 
connected to the chromodomain-remodeling factor Hrp1, which is involved 
in loading of CENP-A at centromeres (357, 361). These observations 
prompted us to investigate Mediator’s role in centromeric function (Paper II). 
In Paper II we discovered that Rrp6 and Med20 together influenced transcript 
levels at the core centromere. To follow up this observation, we performed 
RNA sequencing in a mutant med20∆/rrp6∆ strain. We wanted to study if 
Med20 and Rrp6 had similar effects on transcription as those we had seen in 
the core centromere. Further more we wanted to find out if deletion of both 
med20+ and rrp6+ had more severe centromeric defects then the single 
mutants alone (Paper III). 
In addition to the findings presented in Paper III, the RNA sequencing 
analysis uncovered an unexpected result, a significant increase in transcripts 
mapping to tRNA genes. The observation was surprising since Mediator is 
known to specifically regulate Pol II genes, but not Pol III dependent genes. 
However, the observed effect was very strong and we therefore set out to 
further elucidate Mediator’s effect on tRNA transcription (Paper IV). 
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3 RESULTS AND DISCUSSION 
3.1 Paper I 
In S. cerevisiae, the subtelomeric region flanks the telomere and consists of 
the Yʹ′ and X elements that are characterized by their chromatin state. Y′ 
region is highly enriched in nucleosomes and display high levels of H4K16 
acetylation. In contrast, X element lacks a defined nucleosomal structure, is 
bound by Sir proteins, and has very low levels of H4K16 acetylation. Sir 
proteins that insure transcriptional silencing of the X element maintain the 
hypoacetylated state. The histone deacetylase Sir2 removes acetyl group from 
H4K16 and this activity is counteracted by the histone acetyltransferase Sas2. 
The interplay between these two enzymes decides the boundary between 
silenced and transcriptionally active chromatin. Impaired balance of histone 
modification in the X element is found in aging cells, implicating the 
importance of the X element and its chromatin states for the life span of the 
cell.  
Mediator had previously been shown to affect chromatin silencing of 
telomeres (162). Our, initial investigations uncovered that deletion of MED16 
caused a specific transcriptional increase at genes close to telomeres (Figure 
1A). However, the transcriptional activity at the subtelomeres in MED16 
deletion mutant was fluctuating between a silenced and a desilenced state 
(Figure 1B). In contrast, a med5∆ strain demonstrated a stable desilencing 
effect resulting in increased Pol II binding to the subtelomeric region (Figure 
1D). Mediator localizes to the bordering regions of the X element, and 
deletion of MED5 caused significant decrease of Mediator occupancy at both 
these locations (Figure 2B and C).  
The balance between Sir2 and Sas2 was also disrupted in med5∆ (Figure 10 
of this thesis). While Sas2 binding increased significantly in the X element, 
the opposite was observed for Sir2 (Figure 3A-D). As a consequence, the 
H4K16ac levels were increased in the X element, demonstrating the 
functional significance of Med5 for maintaining a proper boundary between 
hypo- and hyperacetylated regions. In addition, deletion of MED5 caused a 
20 % decrease in replicative life span of the S. cerevisiae cells. 
Our investigation demonstrated that several Mediator subunits influence 
transcriptional activity at the subtelomeres (e.g. Med5, Med7, Med16). How 
Mediator exerts this control is still unclear. The observation that Mediator 
binds to the bordering regions, but not the X element itself raised the question 
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how Mediator’s regulatory function is transmitted into the X element. We 
found that the Mediator and Sir3 compete for binding to mononucleosomes 
in vitro (Figure 5B). Furthermore, we had previously shown that the 
association between Mediator and the histone tail is inhibited by acetylation 
of H4K16. It is possible that Mediator impedes access of Sas2 to H4K16 and 
therefore inhibits Sas2 dependent spread of H4K16ac. Deletion of MED5 
could cause reduced Mediator binding at the border of X element and thus 
allow Sas2 activity to continue further into the X-element. In fact, it has later 
been shown that Med5 physically interacts with the H4-tail (161). This 
correlates with our finding that without Med5, Mediator is lost from the 
subtelomeric regions and provides a mechanistic explanation for Mediator’s 
role in subtelomeric transcriptional regulation.    
Mediator is involved in regulating the silenced state of several genetic 
regions. For instance, the fluctuating chromatin state observed at the telomere 
in the med16∆ mutant also affected mating type loci. During mating in S. 
cerevisiae, the cells secrete pheromones to induce structural projections 
called shmoo. The cells’ response to α cell mating pheromone (α factor) is 
dependent on the chromatin state of the mating type loci (362). Deletion of 
MED16 resulted in less response to the α factor caused by a metastable 
chromatin phenotype. Our results indicate that Mediator may not only affect 
telomeres but also other silenced regions. Indeed, further research revealed 
Figure 10. Mediator influences the boundary between euchromatin and 
heterochromatin at telomeres. 
A) Mediator binds to deacetylated H4K16 and blocks Sas2 ability to acetylate H4K16. B) 
Loss of Med5 impairs Mediator’s ability to interact with H4K16, allowing Sas2 to acetylate 
H4K16, which in turn inhibits binding of Sir proteins. 
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that Mediator also play a role in the maintenance of heterochromatin at S. 
pombe centromeres (Paper II). 
3.2 Paper II 
We set out to investigate if Mediator, apart from its effect at telomeres, also 
could influence the chromatin state at centromeres. We decided to use S. 
pombe as our model systems, since its centromeres resemble those found in 
human cells (331). The microtubule destabilizing drug thiabendazole (TBZ) 
is commonly used for investigating centromeric defects in S. pombe. Genetic 
screening identified a number of Mediator head-module mutants, including 
med18Δ and med20Δ, which were especially sensitive to TBZ (Figure 1A). 
Med18 and Med20 form a flexible subcomplex of the head module. Med20 is 
the most external of the two subunits and deletion of med18+ causes 
disassociation of Med20 from the Mediator complex, whereas deletion of 
med20+ does not affect Med18 (104). We decided to focus our investigation 
on Med20’s role in centromere function. 
Mutations in the RNAi machinery cause defects in centromere function, since 
it is required to produce siRNA molecules used for heterochromatin 
assembly. In our experiments we used the endonuclease Dcr1, which is an 
integral part of the RNAi pathway, as a positive control. By DAPI-staining 
DNA and immunostaining tubulin, we could monitor the effects of med20+ 
deletion on centromere function. We found that the med20∆ mutant caused 
the same elevated levels of chromosome segregations defects as those 
observed in the dcr1∆ strain (Figure 1C-D).  
The heterochromatin structure of the pericentromeric regions is essential for 
proper centromeric function. We found that the levels of the heterochromatin 
marker H3K9me and the Swi6 protein were reduced in the med20∆ mutant 
strain. Since the formation of heterochromatin is dependent on siRNA 
species, we also wanted to see if their levels were changed. Indeed, the 
siRNA levels were reduced in the med20+ deletion strain, even if the 
reduction was less severe than that observed in the dcr1∆ mutant strain.  
Heterochromatin formation causes gene silencing in the pericentromeric 
regions and disruption of this chromatin structure should therefore cause 
increased transcriptional activity. Using chromatin immunoprecipitation 
followed by deep sequencing we found that Pol II binding was increased over 
the pericentromeric regions in med20∆ mutant strain, but not in the 
neighboring euchromatin regions (Figure 2A). Transcription of the 
centromere is normally restricted to the S-phase of the cell cycle and we 
therefore performed a time curve experiment of Pol II binding in 
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synchronized cells. The increase of Pol II binding was indeed specific for the 
S-phase (Figure 2D). Investigation of Mediator binding also revealed a cell 
cycle dependent association with the pericentromeres (Figure 2C). However, 
deletion of med20+ did not cause any change in Mediator binding compared 
to wt.  
Our studies also revealed that transcripts from imr and otr were increased 
during the S-phase (Figure 2F-G). However, these transcripts continued to be 
higher than those observed in wt cells, also during the rest of the cell cycle. A 
possible explanation for this discrepancy could be that loss of Med20 disrupts 
the connection between the pericentromeric transcripts and the RNAi 
machinery and thus decreases the degradation rate of ncRNA into siRNA. 
Therefore the transcripts remain until the next S-phase. This model could also 
explain why deletion of med20+ causes increased ncRNA transcription but 
reduced siRNA levels.  
To investigate Mediator’s effects on silencing of the pericentromere in more 
detail, we performed a tiling array assay. The med20∆ mutant caused 
increased expression of the pericentromeric transcripts compared to wt 
(Figure 3E-F). Although dcr1∆ causes a much higher transcriptional increase 
than med20∆ alone, deletion of these two genes in combination, causes an 
additive effect. This would suggest that Med20 does not work specifically in 
the RNAi pathway. It is more likely that the Mediator works upstream of 
RNAi pathway and contribute to increased Pol II transcription. Perhaps the 
increased transcript levels get distributed between the RNAi-dependent 
pathway and the exosome pathway.  
Desilencing of the pericentromeric region was further demonstrated by 
analysis of an ura4+-marker placed in otr, imr, and cnt (Figure 3A). These 
markers were not expressed in wt cells and deletion of dcr1+ only caused a 
desilencing of the otr and imr regions, but did not affect cnt. In contrast, the 
med20∆ mutant caused increased transcriptional activity in otr, imr, as well 
as in cnt. We found this observation interesting, since it distinguished the role 
of Med20 in centromere regulation from that of the RNAi machinery. The 
second RNA degradation pathway involved in centromere regulation utilizes 
the exosome. We therefore wanted to see if Med20 was involved in the 
RNAi-independent pathway at the core centromere. The expression of core 
centromere transcripts has only been described in a small number of 
publications (363). One reason for this is that the base level of transcription is 
very low and difficult to detect. We deleted rrp6∆ in combination with 
med20∆ and could detect cnt transcripts (Figure 3G). This result suggested to 
us that the RNAi-independent RNA degradation pathway is needed to 
regulate core centromere transcripts.  
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RNA Polymerase II
Mixture of canonical nucleosomes and CENP-A containing nucleosomes
ncRNA
CENP-ACanonical H3
Mediator - med20∆
Canonical nucleosomes only
Figure 11. A potential mechanism for Mediator dependent regulation of core 
centromere function. 
A) Mediator inhibits Pol II activity at cnt, allowing CENP-A to be reincorporated into 
centromeric nucleosomes after DNA replication. B) Loss of Med20 from the Mediator leads 
to increased Pol II transcription and higher nucleosome turn over at the centromere. As a 
consequence stable association of CENP-A with the centromere is impaired, leading to 
centromere dysfunction and chromosome segregation defects.  
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The chromatin structure at the core centromere is characterized by a unique 
nucleosome composition including the centromere specific H3 variant 
CENP-A, which replaces the canonical H3 at many of the nucleosomes (328). 
Since loss of Med20 caused desilencing of cnt, we wanted to see if it also 
affected CENP-A levels. Indeed, centromeric CENP-A levels were decreased 
in the med20+ deletion mutant (Figure 4A-B). In fact, the total amount of 
CENP-A in the cell was significantly reduced in the med20Δ strain (Figure 
4C), even if the transcript levels encoding for CENP-A remained unchanged 
(Figure 4D).  
We could conclude that expression of the cnp1+ gene was unaffected, but 
without proper centromere incorporation, the translated CENP-A protein is 
rapidly degraded. During replication, CENP-A is removed from the core 
centromere and the DNA is exposed, enabling transcription of the region 
(329). We hypothesized that deletion of med20+ caused increased Pol II 
activity at the core centromere, which could inhibit CENP-A incorporation. 
By treating the cells with the RNA polymerase inhibitor Actinomycin D we 
hoped to restore CENP-A levels at the centromere. Immunostaining 
experiments did indeed demonstrate that inhibition by Actinomycin D could 
partly restore CENP-A incorporation at the core centromere (Figure 4E). 
The combined data of the study prompted us to suggest a model in which 
Med20 acts to repress Pol II activity at the centromere (Figure 11 in this 
thesis). Without Med20 present, the activity of Pol II will increase, which in 
turn will interfere with CENP-A incorporation, causing kinetochore 
destabilization and chromosome segregation defects. 
3.3 Paper III 
In fission yeast, packaging of pericentromeric regions into heterochromatin is 
required for proper kinetochore assembly and chromosome separation. 
Heterochromatin formation is a very complicated, multistep process. Parts of 
the pericentromeric regions are transcribed during S phase and these 
transcripts are used to direct heterochromatin assembly via the RNAi 
pathway. Recently, an alternative regulatory pathway has been suggested, 
which involves the exosome RNA degradation machinery and functions in 
parallel to the RNAi pathway (364). In support of this idea, the simultaneous 
loss of both the exosome component Rrp6 and the RNA helicase required for 
siRNA formation, Dcr1, leads to additive effects with a strong increase in 
pericentromeric transcription levels.  
We wanted to better understand how loss of Med20 could cause the defects in 
centromere function described in Paper II. Especially, we wanted to find out 
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if Med20 functioned via the exosome pathway, since in Paper II, we had 
observed that loss of Med20 in combination with Rrp6 caused increased 
levels of cnt transcripts. We now used strand-specific RNA sequencing and 
analyzed how loss of Med20 affects centromeric transcription. We found that 
the levels of pericentromeric transcription were very low and not notably 
affected by loss of Rrp6 (Figure 1A and B). In med20Δ we observed a ~20-40 
fold increase in pericentromeric transcript, which could be reduced by the 
simultaneous deletion of rrp6+. We also used RT-PCR to quantify transcripts 
from the dh region and obtained supporting results, i.e. that loss of Med20 
causes upregulation of dh transcripts, which can be partially reversed when 
rrp6+ is deleted (Figure 2A). 	  
tRNA genes play an important role in the formation of chromatin boarders 
between the pericentromeric imr and the core centromere. Since loss of 
Med20 impairs tRNA gene transcription (Paper IV), we wondered if changes 
in centromeric tRNA transcription patters could explain the observed increase 
in pericentromeric transcript levels. Based on our findings in a reporter 
system with a centromere elements and an ura4+ gene, we rejected this idea 
(Figure 2B).  Deletion of Med20 did not seem to affect boundary function of 
the centromeric tRNA gene. 
Production of siRNA from pericentromeric transcripts guides the assembly of 
heterochromatin at the pericentromere and we wondered if Rrp6 could 
influence this process in med20∆ cells. Especially since the increased 
transcript levels that we now observed in the pericentromeric region upon 
loss of Med20 overlapped with regions of siRNA production (Figure 2C). To 
address this possibility, we isolated small RNA from wild type and mutant 
cells and performed strand-specific small RNA sequencing. As expected 
from our previous publication (Paper II), we observed a reduction of siRNA 
production in the med20∆ cells. However, this effect was not reversed in the 
med20∆/rrp6∆. We therefore concluded that even if loss of Rrp6 decreases 
pericentromeric transcripts levels associated with loss of Med20, Rrp6 did 
not affect the changes in siRNA production observed in med20Δ cells. 
Next, we monitored if Rrp6 could influence the chromosome segregation 
defects seen in med20Δ. To this end we used the same approach as in Paper II 
and monitored chromosome segregation following tubulin and DAPI 
staining. There were no clear effects on chromosome segregation in the 
rrp6Δ strain and loss of Rrp6 did not affect the defects in chromosome 
segregation observed in med20Δ (Figure 4A and B). Therefore, even if loss 
of Rrp6 can reduce the increased pericentromeric transcript levels seen in 
med20Δ, the exosome component did not affect the defects in chromosome 
segregation. 
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Based on our results we could conclude that even if the exosome is involved 
in regulating the stability of Mediator dependent transcripts, it is not required 
for the chromosome segregation effects observed in the med20+ deletion 
strains. The effects of Mediator and exosome at the centromere is however 
not completely independent. When we analyzed if Rrp6 could affect the 
changes centromeric histone modifications caused by med20Δ we noted that 
H3K9me, a prominent marker for heterochromatin formation in the 
pericentromeric region was decreased med20∆ cells (as reported in paper II) 
and that the H3K9me levels was restored to near wt levels in the 
med20/rrp6∆ strain (Figure 5C). 
3.4 Paper IV 
In paper II we found that loss of Med20 caused increased core centromere 
transcription. These transcripts were rapidly degraded by the exosome and to 
study them, we had to inactivate the exosome by deleting the rrp6+ gene. We 
wondered if exosome degradation could mask effects of med20∆ also on 
other transcripts. We therefore sequenced polyadenylated RNA isolated from 
wild type and mutant strains. Our analysis revealed a strong increase of Pol 
III dependent transcripts, including tRNA, snRNA, and snoRNA in 
med20∆/rrp6∆ cells. This finding was unexpected, since Mediator is a 
regulator of specifically Pol II transcription and Pol III transcripts are not 
normally polyadenylated. 
Defective tRNA may be degraded in a process, which involves 
polyadenylation by the TRAMP complex, which targets the tRNA for 
destruction by the exosome. We therefore hypothesized that loss of Med20 
leads to the formation of aberrant tRNA transcripts, which are polyadenylated 
by TRAMP. However, since rrp6+ is deleted, these aberrant transcripts 
accumulate in the med20∆/rrp6∆ cells. Indeed, we noted that the 
polyadenylated tRNA were much longer than expected, about 200-250 nt 
compared to an expected length of 70-100 nt (Figure 2A). To follow up this 
observation, we mapped transcripts at a number of individual tRNA genes. 
Whereas the 5ʹ′ was identical to the normal tRNA, mapping of the 3ʹ′ ends 
revealed that the existence of long, aberrant transcripts. Based on our 
observations, we concluded that deletion of med20+ might lead to 
transcription termination read-through at tRNA gene loci. We could support 
this conclusion using quantitative PCR analysis and demonstrate that the long 
transcripts were rapidly degraded when transcription was inhibited with the 
drug 1,10-phenantroline (Figure 3B). We could also observe the read-through 
transcript using Northern blot analysis (Figure 3C). 
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An interesting characteristic of the TRAMP complex is that during poly(A) 
synthesis it introduces a rather high frequency of bases other than A (Figure 
4A and B). To address if the TRAMP complex was responsible for the 
poly(A) tails on tRNA, we analyzed reads with respect to poly(A) content. 
Indeed, poly(A)-containing reads that could be mapped to the tRNA gene 
GLN01 contained high proportion of bases other than A, strongly supporting 
the idea that polyadenylation of tRNA transcripts is performed by Cid14, the 
atypical poly(A) polymerase present in the TRAMP complex. 
We also observed that other Pol III-dependent transcripts were affected in the 
med20∆/rrp6∆ strain.  Analyzing 5S rRNA genes, we observed on average a 
9-fold increase in the mutant compared to wild type cells (Figure 5A). We 
also observed a very strong increase in polyadenylated snoRNA and snRNA 
transcripts (Figure 5B-D). In addition, the Pol III transcripts coding for 
RNase P and RNase MRP RNAs were also increased in med20∆/rrp6∆. 
In budding yeast MED20 interacts genetically with MAF1, which encodes an 
evolutionary conserved repressor of Pol III transcription. We therefore 
addressed if Maf1 could mediate Med20’s effect on Pol III transcripts. We 
used reverse transcription followed by quantitative PCR, to analyze the 
production of long read-through tRNA transcripts, but the levels of these 
were not significantly affected by the loss of Maf1 (Figure 6A). Maf1 is 
activated by dephosphorylation and we also analyzed if Med20 could affect 
this process. We found that the ratio of dephosphorylated relative 
phosphorylated Maf1 was slightly higher in the med20∆ cells (Figure 6C). 
Therefore, if anything, Maf1 counteracted the effect of Med20 on Pol III 
transcription. Since there is so far no evidence to support a physical 
connection between Mediator and the exosome, we currently believe that the 
effects of Med20 and Rrp6 on aberrant transcript levels are additive, i.e. 
Mediator regulates the transcriptional activity and the exosome is needed to 
degrade the aberrant transcripts.  
As demonstrated in our report, mutations in fission yeast Mediator influences 
both transcription of Pol II and Pol III genes required for translation. These 
observations are somewhat related to findings in budding yeast, which has 
demonstrated that Med20 is required for transcription of ribosomal proteins 
genes. Based on our studies we therefore suggest that Med20 takes part in a 
pathway that coordinates expression of ribosomal protein genes with Pol III 
transcription. Unexpectedly, our study suggests that Med20 is involved in 
repressing certain activities of Pol III. The most likely explanation is that 
changes in Pol III transcription is due to indirect effects, probably via Pol II 
dependent genes involved in Pol III function, but we can still not completely 
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rule out a direct effect of mutant Mediator on the Pol III transcription 
machinery.  
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4 CONCLUSION 
The Mediator complex is a diverse and multi-functional complex (145). In 
this thesis we aim to expand our knowledge of Mediator’s involvement in 
ncRNA and chromatin regulation. We show that Mediator is important for 
the maintenance of silenced chromatin regions such as telomeres, mating type 
loci, and centromeres. At S. cerevisiae telomeres, Mediator is involved in 
regulating the exact border between silenced and transcriptionally active 
regions. Mutations affecting Mediator subunits disturb this function and have 
consequences for replicative ageing in yeast cell. If these findings are of 
relevance for telomere maintenance and replicative ageing also in higher cells 
remains to be investigated. 
Our findings also demonstrate that Mediator dependent regulation of 
centromeric transcription is important for proper chromosome segregation. 
Mutations affecting the Mediator head module cause defects in 
heterochromatin formation and reduce CENP-A incorporation at fission yeast 
centromeres, which in turn results in chromosome segregation defects. 
Mutations in genes encoding Mediator subunits have been linked to the 
development of several forms of cancer (184) and we believe that our 
findings may be of relevance for understanding the oncogenic potential of 
some of these mutations. Chromosomal instability is a driving force in 
tumorigenesis and CENP-A has for instance been suggested as a prognostic 
marker in breast cancer (365). In future work, we intend to analyze if 
Mediator can influence chromosome stability in mammalian cells. 
In the thesis, we have also presented data demonstrating that Mediator can 
influence transcription of ribosomal protein genes as well as Pol III 
dependent genes. The Mediator-dependent regulatory pathway characterized 
here is parallel to the repressive pathway involving the classical repressor of 
Pol III transcription, Maf1. Since Mediator is at the crossroad of many 
different signaling pathways and in a position to sense the nutritional status 
of the cell, Med20 could be involved in coordinating Pol II responses to 
cellular stress with regulation of Pol III activity. However, the underlying 
mechanisms of this coordination are still obscure and more work is clearly 
needed to establish the relevance of these ideas. 
In conclusion, our work reinforces the idea that Mediator is more then a mere 
mediator of signals from activator proteins to the basal Pol II transcription 
machinery at the promoter. Mediator influences vital cellular processes such 
as cell division, replicative ageing and even Pol III transcription. The 
complexity of Mediator function is still largely uncharted and the future will 
bring many new exciting discoveries about this multi-talented complex. 
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